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RNA   interference   (RNAi)   is   an   evolutionarily   conserved   process   that   regulates   gene  
expression.  Host  cells  and  viruses  interact  in  many  ways,  including  through  miRNAs  and  
RNAi.  Viral  miRNAs  are  encoded  when  viruses,  specially  including  the  the  polyoma  and  
herpes  families,  are  transcribed  in  the  nucleus.  Some  viral  miRNAs  function  to  regulate  
??????????????????????????????? ???????????????????????????????????????????????????  in  
great  detail.  A  miRNA  can  be  encoded   late  during   infection,  as   it   is  by  SV40,  a  model  
polyomavirus.  This  downregulates  early  viral  gene  expression  by  directing  mRNA  RISC-­
mediated   cleavage.   As   more   polyomaviruses   are   discovered   that   are   associated   with  
human  disease,   it  becomes  more   important   to  understand   their   function  and   to  uncover  
whether   these   emerging   viruses   encode  miRNAs.   The   work   presented   here   shows   the  
discovery  of  several  viral  miRNAs  in  human  polyomaviruses?JCV,  BKV,  and  MCV.  In  
addition,   I   found   that   viral   miRNAs   have   the   evolutionarily   conserved   function   of  
negatively  regulating  viral  early  gene   transcripts  at  a   late  stage   in   the   infection.  During  
viral   replication,   viruses   utilize   the   miRNA   components   of   RNAi.   However,   in  
invertebrate  organisms  RNAi  also  actively  defends  against  viral  infection.  It  is  still  being  
   viii  
debated,  though,  whether  RNAi  plays  an  antiviral  role  in  mammalian  cells.  Should  it  be  
true   that  RNAi   is   an   antiviral   response   in  mammalian   cells,   then  what   is   predicted   by  
such   a   scenario   is   inconsistent   with   my   studies.   I   have   found   that   RNAi   is   strongly  
inhibited  in  the  early  stages  after  viral  infection.  Studies  with  a  chemical  mimic  of  viral  
infection  (poly  I:C)  imply  that  the  innate  cellular  immune  response  is  responsible  for  this  
inhibition.  I  investigated  the  molecular  changes,  in  response  to  viral  infection,  (e.g.  poly  
ADP-­ribosylation  of  Ago2)  in  the  RNA-­induced  silencing  complex  (RISC).  I  determined  
that   the   inhibition   of   RNAi   is   brought   about   by   components   of   the   innate   response.  
?????????????? ??????????????????????????????????????????????? ???????????????????????
the  host  innate  immune  response  in  mammalian  cells.  Furthermore,  I  found  mir-­17  family  
attenuates  a  subclass  of   interferon-­stimulated  genes.     An  understanding  of  viral  miRNA  
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Chapter  1:  Introduction  
1.1  Viruses  and  RNA  interference  (RNAi)  
The   evolutionarily   conserved   process   of   post-­transcriptional   regulation   of   gene  
expression-­directed  by  small  RNAs  (siRNAs  or  miRNAs),  is  known  as  RNA  interference  
(RNAi)  (Illustration  1)  (Umbach  and  Cullen,  2009).  Small  RNAs  enter  a  protein  complex  
called  the  RNA-­induced  silencing  complex  (RISC)  and  bind  directly  to  messenger  RNA  
(mRNA)  targets.  This  results  in  the  cleavage  of  the  transcript  or  specific  inhibition  of  the  
translation   of   the   transcript   (Illustration   1B).   It   is   believed   that   70%   of   all   human  
transcripts   are   regulated   by   miRNAs.   Several   DNA   virus   families?   including   the  
polyomaviridae  and  herpesviridae  familes  ?  also  take  advantage  of  this  strategy  for  gene  
regulation   and   encode   small   RNAs   called   microRNAs   (miRNAs)   (Boss   et   al.,   2009;;  
Cullen  BR  2009;;  Sullivan  et  al.,  2005;;    Kim  et  al.,  2009;;  Eash  et  al.,  2006).  The  functions  
of  the  polyomaviridae  and  herpesviridae  miRNA  are  still  under  investigation.  However,  
several  hypotheses  exist  for  their  function.  One  relevant  to  my  work  suggests  that  viruses  
encode  miRNAs  and  utilize  host  RNAi  machinery  to  evade  the  host  immune  response.    
Whether  RNAi  plays  an  antiviral  role  in  mammalian  cells  is  a  hotly  debated  topic  
(Umbach  et  al,  2009).  Several  reports  show  that  mammalian  viruses  encode  proteins  that  
can  inhibit  RNAi  activity  (Bennasser  et  al.,  2005,  Haasnoot  et  al.,  2007,  Li  et  al,  2004).  
However,  these  studies  were  not  conducted  in  the  context  of  viral  infection  and  involved  
only  exogenous  over-­expression  of  the  viral  proteins.  In  addition,  knocking  out    




                                                   
  
Illustration  1.1:  RNA  interference    A.  RNAi  triggered  by  viral  infection.    
                                                                                                                    B.  miRNA  regulation  of  endogenous  transcripts.  
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components  of  the  RNAi  machinery  in  mammalian  cells  increases  the  replication  of  some  
viruses.  This  is  likely  due  to  a  loss  of  endogenous  cellular  miRNAs  that  are  fortuitously  
complementary   to   viral   transcripts   (Otsuka   et   al.,   2007).   To   date,   no   viral-­specific  
siRNAs  have  been  detected  in  studies  conducted  by  small  RNA  cloning  or   though  deep  
sequencing  of  viral   infected  mammalian  cells   (Umbach  et  al.,  2010).  At   the  same  time,  
small  siRNAs  associated  with  the  antiviral  response  are  readily  detectable  in  plants  and  
insects  during  infection  (Ding  and  Voinnet,  2007).  Thus,  greater  understanding  is  needed  
concerning  the  role  of  RNAi  as  an  antiviral  defense  in  mammalian  cells.  
1.2  Polyomavirus-­encoded  miRNAs    
Polyomaviruses  are  a  family  of  small  DNA  tumor  viruses.  Both  mouse  and  
monkey  polyomaviruses  infections  have  been  shown  to  cause  tumorigenesis  in  the  host.  
In  the  early  1970s,  the  human  polyomaviruses  (JCV  and  BKV)  were  discovered  and  have  
been  implicated  in  several  human  diseases  (Padgett  BL,  1976;;  Knowles  et  al.,  2003).  
Specifically,  BKV  induces  nephritis  in  some  kidney  transplant  recipients  and  JCV  causes  
progressive  multifocal  leukoencephalopathy  (PML)  in  immunocompromised  patients  
suffering  from  AIDS.  In  2008,  a  high  throughput  technique  led  to  the  discovery  of  a  new  
polyomavirus  (Merkel  cell  polyomavirus)  that  can  cause  an  aggressive  human  skin  
cancer  (Feng  et  al.,2008).  MicroRNAs  are  regulatory  small  RNAs,  consisting  of  22  
nucleotides.  Researchers  have  focused  on  studying  these  small  molecules;;  they  are  
involved  in  the  animal  development,  apoptosis,  and  human  cancer.    Five  polyomavirus  
microRNAs  have  been  identified.    Recent  work  indicates  that  despite  little  sequence  
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similiarty,  the  polyomavirus  miRNAs  have  an  evolutionarily  conserved  function  of  
regulating  early  viral  protein  production  to  help  escape  the  host  immune  system  
(Grundhoff  and  Sullivan,  2011).  As  these  miRNAs  are  functionally  conserved,  blocking  
miRNA  function  could  be  a  useful  strategy  for  therapeutic  disease  interventions  in  the  
future.  
1.2.1  MicroRNA  biogenesis  
Small  RNAs  can  serve  as  effectors  to  direct  post-­transcriptional  regulation  of  gene  
expression   (Cullen,   2009).   Endogenous   miRNAs   arise   from   a   series   of   nucleolytic  
processing   events   starting   in   the   nucleus   and   into   the   cytosol   by   several   RNase   III  
endonuclease   protein   complexes.   A   class   of   small   RNAs   is   called   microRNAs   and  
consists  of  approximately  21-­23  nucleotides  (Kim  et  al.,  2009).  In  short,  microRNAs  are  
generated   from   hairpins   transcribed   by   RNA   polymerase   II.   The   primary   transcripts,  
called  pri-­miRNAs,  are  processed  into  60-­80  bp  short  hairpins  known  as  pre-­miRNAs  by  
a  microprocessor  composed  of  Drosha/DGCR8  complex  (Kim  et  al.,  2009).    
The  Pre-­miRNAs   are   exported   into   the   cytosol   from   the   nucleus   by   exportin-­5.  
The   short   hairpins   are   then   further   matured   into   22   nucleotide   strands   by   the   Dicer  
complex,   composed   of   Dicer/TRBP   (Chendrimada   et   al.,2005).   The   mature   22  
nucleotides   are   finally   incorporated   into  RNA?induced   silencing   (RISC)   complex.  The  
functions  of  miRNAs  depend  on  the  complementary  sequences  between  the  miRNA  and  
?????? ??? ???? ??????? ??????????? ?????? ??? ?? ?????????????????? ?????????????? sequence  
between   the   two   strands,   the   target   strand   is   cleaved   in   the  middle   of   the   binding   site,  
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which  is   located  9-­10  nucleot????????????????  ends  of   the  miRNA  (Bartel,  2004).  When  
there   is   an   imperfect   complementarity   between   the   two   strands,   the   target   genes   are  
typically   translationally   repressed   by   the   RISC   complex.   Researchers   have   recently  
identified   over   1000   human  miRNAs.   These   miRNAs   are   involved   various   processes,  
including  the  immune  response,  apoptosis,  animal  development,  and  cancer  (Kim  et  al.,  
2008).    
  In  the  field  of  virology,    diverse  viruses,  including  an  ascovirus,  several  members  
of   the   Herpesviridae   and   Polyomaviridae   and   Retrovirus,   have   been   shown   to   encode  
miRNAs   that   autoregulate   viral   gene   expression   (Hussain,   Taft,   and   Asgari,   2008;;  
Gottwein   and  Cullen,   2008;;   Pfeffer,   2008,  Rodney   e   al.,   2012).  Reports   that  HIV   also  
encodes  siRNA  are  being  debated.      The  following  herpesvirus  family  encodes  miRNAs:  
human   cytomegalovirus   (CMV),  Herpes   Simplex  Virus   (HSV-­??? ????????????? ???????-­
associated   herpesviruses   (KSHV),   and   Epstein   Barr   virus   (EBV)   (Cullen,   2006).  
Polyomaviruses   with   varying   host   ranges   also   encode  miRNAs:   from  murine   (MuPV)  
andmonkey   (Simian   Vacuolating   virus   40)   to   human   polyomaviruses   (BKV,   JCV   and  
MCV)  (Sullivan  et  al.,  2008;;  Seo  et  al.,  2008;;  Seo  et  al.,  2009).    
  
1.2.2  The  Polyomavirus  family  
Polyomaviruses   have   been   used   to   discover   important   tenants   of   molecular  
biology   such   as   alternative   splicing   and   mechanisms   of   oncogenesis.   Polyomaviruses  
consist   of   a   family   of   small,   naked   capsid,   circular,   double-­stranded   DNA   genomes  
(Sullivan  et  al.,  2005).  The  polyomavirus  family  has  a  narrow  host  range  in  which  each  
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virus  can  replicate  actively  in  the  susceptible  species.  The  polyomavirus  family  also  has  a  
highly  conserved  genome  structure  for  gene  expression.  The  approximately  ~  5  kilobase,  
closed  genome  has  an  early   transcript  expressed   in  one  direction  and   the   late   transcript  
expressed  in  the  other  direction.  T  antigen  translated  from  the  early  transcript  is  a  well-­
studied  oncoprotein  involved  in  tumorigenesis.    
The   mouse   polyomavirus   has   been   a   good   in   vivo   model   for   the   study   of  
tumorigenesis.   It   expresses   middle   T   antigen?   distinct   from   the   other   polyomavirus  
families.  The  SV40  virus,  discovered  50  years  ago,  has  been  a  standard  model  virus  of  
polyomaviral   biology.   As   an   old-­world   primate   polyomavirus,   it   was   identified   as   a    
contaminant  of  the  polio  vaccine.  Although  mostly  discredited,  some  scientists  continue  
to   debate   whether   the   polio   vaccine   leads   to   the   occurrence   of   cancer   in   the   human  
population.  Nevertheless,  SV40   is   still  broadly  used   for   studying  polyomavirus  biology  
as  an  etiological  agent  for  cancer.    
In   1971,   two   human   polyomaviruses,   JC   virus   and   BK   virus,   were   discovered  
(Eash  et  al.,  2006).  Both  are   related   to  serious  human  diseases   in   immunocompromised  
patients.   Over   70%   of   the   human   population   tests   positive   in   serological   testing  
Researchers   recently   identified   three   human   novel   polyomaviruses   (Eash   et   al.,   2006).  
Both   Karolinska   Institutue   (KI)   and  Washington   University   (WU)   virus   were   isolated  
from  respiratory  tract  samples.  It  remains  to  be  seen,  however,  whether  these  viruses  are  
closely  related  as  etiological  agents  for  respiratory  disease.    
In  2008,  the  first  polyomavirus  associated  with  human  cancer  was  identified  with  
new,  molecularly-­based   high   throughput   technology   (Feng   et   al.,   2008).  The   follow-­up  
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papers   demonstrated   a   number   of   findings.   First,   the   virus   is   closely   linked   with   the  
aggressive   skin   cancer,   Merkel   cell   carcinoma;;   80%   of   clinical   samples   contain   an  
intergraded  copy  of  the  Merkel  Cell  Polyomavirus  genome.  In  addition,  permanent  viral  
integration  into  the  genome  is  essential  for  skin  cancer  development.    
  
1.2.3  Polyomaviral-­encoded  miRNAs    
Over   the   last   eight   years,   miRNAs   have   been   isolated   from   different   species-­
specific  polyomaviruses.  Using  bioinformatics   approaches   combined  with  northern  blot  
analysis,  two  polyomaviral  miRNAs  were  detected  from  each  species  of  polyomavirus?
murine   polyomavirus,   SV40,   three   human   polyomaviruses   (BKV,   JCV   and  
MCV)(Sullivan   et   al.,   2005;;   Seo   et   al.,   2008;;   Seo   et   al.,   2009).   Interestingly,   both  
miRNAs  are  processed  from  the  same  precursor  and  have  distinct  functions  from  cellular  
miRNAs.  As  part  of  the  polyomavirus  life  cycle,  these  viruses  use  the  host  machinery  to  
generate  miRNAs  as  a  strategy  for  the  regulation  of  gene  expression.    
The   primary   transcripts   synthesized   from   the   host   polymerase   II   are   processed  
into   ~80   nucleotide   host  microRNA  processors   even   though   each   virus   has   a  minutely  
different  miRNA  in  length.     miRNA  deep  sequencing  has  mappe????????????????ends  of  
miRNA,  indicating  that  these  viruses  have  a  majority  of  22  nucleotide-­matured  miRNAs  
with   a   minor   proportion   with   21   nucleotides.   These   short   variants   are   most   likely  
generated  from  alternative  two  steps  of  miRNA  biogenesis  and  it  is  questionable  whether  
these  viral  miRNA  variants  will  have  any  distinct  function.    
Interestingly,   although   possessing   little   or   no   sequence   identity,   polyomaviral  
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miRNA   genomic   locations   are   positionally   conserved.   The   mouse   and   MCV  
polyomaviral  miRNAs  are  located  near  to  one  another  in  the  genome  alternatively  to  the  
SV40-­related   miRNAs.   Considering   that   the   miRNA   sequences   are   not   very   similar,  
positional  conservation  is  intriguing.  The  MCV  miRNAs  are  isolated  from  two  different  
isotypes   of   Merkel   cell   polyomaviruses   (Seo   et   al,   2009)   whose   precursors   have   a  
polymorphism  in  the  hairpin  but  not  in  the  miRNA  sequences.  The  strictness  in  sequence  
composition   of   the   hairpin   sequences   strongly   affects   the   efficiency/biogenesis   of  
miRNAs,  as  evidenced  by  experimental  mutation  (Gottwein  et  al.,  2006).  However,   the  
polymorphic  change   in  MCV  pre-­miRNA  affects  neither   the  biogenesis  of   the  miRNAs  
nor   the   function   of   targeting   mRNAs.   Even   though   the   sequences   among   several  
polyomaviral  miRNAs  are  different  (group  I:  SV40,  JCV,  BKV  miRNAs,  group  II:  muPy,  
???? ????????? ???? ???????? ????????? ??? ??????? ??????????? ????? ???????? ????? ??ral  
miRNAs   are   not   only   important   to   the   virus,   but   there   is   evolutionary   pressure   to   be  
functionally  conserved  across  viral  families.      
  
1.2.4  Polyomaviral  miRNA  function  
The  polyomaviral  late  transcript  is  encoded  antisense  to  the  early  transcript  in  the  
viral  genome  (Sullivan  et  al.,  2005).  The  miRNAs  are  expressed  from  the  late  transcript  
and,  therefore  have  perfect  complementarity  to  their  own  target  transcripts.  Polyomaviral  
miRNAs  are  enriched  in  the  late  viral   lytic  infectious  cycle,  even  though  the  expression  
mechanism  remains  to  be  determined.  Current  hypotheses  include  miRNA  generation  by  
a  polyadenylation   read-­through  mechanism  during   the   late   infection.  More   specifically,  
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miRNAs  are  more  often  processed  from  long,  non-­coding  read-­through  transcripts  of  late  
transcripts   (Chen   et   al.,   personal   communication).   Thus,   polyomaviral   miRNAs   are  
enriched   late   during   infection.   Due   to   their   perfect   complementarity   to   the   target  
transcript,   polyomaviral   miRNAs   act   in   a   siRNA-­like   function   to   cleave   the   target  
transcripts  in  the  middle  of  the  miRNA  binding  site.  The  cleavage  sites  can  be  determined  
using   two  separate  methods:  ????????????????????????????????????????????.  Cellular  
miRNAs,  in  only  rare  cases  cleave  their  target  transcripts,  but  instead  inhibit  translation.  
The   polyomaviral   miRNAs   cleavage   mechanism,   similar   to   siRNA-­like   regulation,   is  
comparable   to   herpesviral   miRNAs   (Sullivan   et   al.,   2005;;   Seo   et   al.,   2008).   Many  
questions   remain   in   the  study  of  polyomaviral-­encoded  miRNAs   including,  what   is   the  
role  of  miRNAs  specifically  expressed  at   certain   times  during  viral   replication     Mutant  
viruses  that  lack  viral  miRNA  expression  have  an    intact  infectious  cycle  and  replication  
cycle   in      in   vitro   cell   culture   conditions.   However,   Sullivan   et   al.   (2005)   have   shown  
reduced  Large  T   antigen   protein   expression   and   a   decrease   in   viral   cytotoxicity   during  
infection.  This  suggests  that  the  miRNAs  have  evolved  to  tightly  tune  the  level  of  its  own  
protein  possibly  to  evade  the  host  immune  system.  During  replication,  large  T  antigen  is  
multifunctional  and  also  is  exposed  to  the  host  adaptive  immune  system.  Knocking  down  
large  T   antigen   expression   late   during   infection   via  miRNA   regulation  might   act   as   an  
escape   mechanism   from   host-­immune   surveillance.   All   of   the   polyomaviral   miRNAs  
currently  isolated  show  autoregulation  of  early  transcripts,  indicating  that  such  a  strategy  
might   be   necessary   for   the   polyomavirus   life   cycle.      If   the   polyomavirus   acts   with   a  
siRNA-­like   function   for   autoregulation,   is   there   any   interaction   between   polyomaviral  
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miRNAs   and   cellular  messenger  RNAs?   It   remains   to   be   seen  whether   these  miRNAs  
target   cellular   messenger   RNAs.   One   possible   scenario   is   that   it   also   functions   as   a  
miRNA   to   regulate   the   host   messenger   RNAs.   However,   even   with   their   conserved  
function,   polyomaviral  miRNA   sequences   differ,   including   changes   in   the   seed   region,  
which  is  an  important  module  for  translational  control.  How  do  these  viral  miRNAs,  with  
different  sequences,  possess  a  conserved  function  to  regulate  the  same  target  genes?    One  
???????????? ??? ????? ????????????????????????????????????? ?????????????????????????????
sharing  the  same  target.  It  is  questionable,  however,  that  a  functional  strictness  makes  it  
possible  to  evolutionally  change  in  the  sequence  of  miRNAs  in  the  virus.  Alternatively,  
the  different  polyomaviral  miRNAs  could  have  a  different  target  repertoire  likely  due  to  a  
strain  specificity  showing  cellular  tropism.  For  example,  a  recent  paper  showed  JCV  and  
BKV  miRNAs  commonly   regulate   the   ??????? ?????????????? ???????? ??????????? ???????
response   gene   (Bauman   et   al.,   2011).  New   techniques   to   search   for   the   viral  miRNAs  
cellular   targets,   such   as   HITS   or   PAR-­CLIP,   have   been   well   developed   and   used  
increasingly   to   identify   novel   functions   for   miRNAs.      Any   future   cellular   targets  
identified   for   the   different   polyomaviral  miRNAs  will   be   helpful   in   providing   a   better  
understa????????????? ????????????????Ziegelbauer  et  al.,  2009).  
  
1.3  RNAi  as  an  antiviral  mechanism  in  plant  and  invertebrate  animals    
RNA   silencing   as   an   antiviral   defense   is   widely   accepted   in   both   plants   and  
invertebrate   animals   (reviewed   in   Ding   and   Voinnet,   2007).   DNA   viruses   make   long,  
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double-­stranded   RNAs   through   overlapping   transcription.   RNA   viruses   also   produce  
double-­stranded  RNAs  during  infection.  Virus-­derived  small  interfering  RNAs  (viRNAs)  
are   produced   during   infection   and   leads   to   the   induction   of   specific   gene   silencing   by  
viRNA-­RNAi  effector  complexes.  The  key  component  of  antiviral  RNA  silencing  is  well  
characterized   in   plant,   flies,   and   worms   using   biochemical   and   genetic   approaches.  
Furthermore,  viral   suppressors   for   gene   silencing  are   expressed  as   a   countermeasure   to  
the  h???????????????? ??????????? ????????????? ???????????????????????????? ????????? ??????
spots)   early   during   viral   infection   but   then   gradually   disappear   (Reviewed   by  
Baulcombe).  Newly  emerging  leaves  are  immune  to  this  same  virus  infection,  implying  a  
protection   of   viral   spread.   This   phenomenon   was   referred   to   as   a   viral   infection  
??????????????????it  was  established  that  this  is  an  example  of  antiviral  immunity  directed  
by  RNA  silencing.  
In   the   model   organism,   Arabidoposis   thaliana,   the   antiviral   defense   of   RNAi,  
mostly   relies  on  Dicer-­like  proteins   (DCL2-­4)   (Bartel,   2004).   It   is   known   that  DCL2-­4  
produces   small   interfering   RNAs   (siRNAs)   with   lengths   from   21-­24   nucleotides  
(Brodersen  and  Voinnet,  2006).  These  are  made  from  a  virus  derived  from  long  double-­
stranded  RNAs  (dsRNAs).  The  respective  mutations  in  the  four  Arabidopsis  DCLs  do  not  
show  critical  changes  in  viral  susceptibility  because  of  the  functional  redundancy  of   the  
DCL  proteins.  Ago1  is  a  major  antiviral  slicer,  but  other  Ago  proteins  are  likely  to  have  a  
????????????????????? ?????????? ??????? ?????????????????? ???????? ??????????????? ?????????
reveal   that  plant  viruses  ubiquitously  possess  a  counter-­measure  for  host  antiviral  RNA  
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silencing  (Li  and  Ding,  2006).  For  example,  a  Cymbidium  ringspot  virus  suppresses  gene  
silencing  by  sequestering  viRNAs  and  prevents  their  incorporation  into  RISC  (Lakatos  et  
al.,  2004).    
In  addition,  the  C  elegans  Dicer  complex  processes  siRNAs  and  miRNAs  to  play  
an  important  role  in  defending  adult  worms  from  VSV,  which  naturally  infects  livestock.  
Lastly,  Felix  et  al.,  (2006)  identified  the  first  virus,  a  nodavirus  (Orsay  virus),  to  naturally  
infect  worms.  Of  significance,  Orsay  virus  easily  infects  C.  elegans  that  are  defective  in  
RNAi.  This  virus  expressed  higher   levels  of  viral  RNA  when  compared   to   infection  of  
the  corresponding  wild-­type  worms.    
In  Drosophilia,   long  double-­stranded  RNAs  produced  by  viruses   are   recognized  
by  the  RNase  III  enzyme  called  Dicer-­2,  and  are  effectively  converted  into  21  nucleotide  
siRNAs   (Hammond,   2005).   The   proof   of   RNAi   as   a   natural   antiviral   defense   in  
Drosophila  has  been  shown  using  several  genetic  studies.  The  Dcr-­2,  R2D2  mutant  flies  
are  highly  susceptible  to  fruit  viruses  compared  to  wild  type  flies.  Van  Rjj  et  al,  (2006)  
show  that  Ago-­2   is   critical   for  antiviral  defense   in  adult   flies.  Ago-­2  defective  flies  are  
susceptible   to   infection   with   several   fly   viruses   including,   DCV   and   CrPV.   Antiviral  
RNAi   in   flies   is   counteracted  by  suppressors   encoded  by  virus.  DCV  virus  expresses  a  
suppressor   which   prevents   the   conversion   of   long   double-­stranded   RNAs   into   21  
nucleotide  siRNAs.  
1.4  Mammalian  antiviral  mechanism  
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Mammalian   cells   recognize   viral   invasion   and   activate   their   sophisticated   self-­
defense  mechanism   called   the   adaptive   immune   response.  This   results   in   limiting   viral  
replication  and  subsequent  secondary  infections.  The  recognition  of  pathogen  invasion  is  
initiated  by  pattern  recognition  receptors  (PRRs)  (Akira  et  al.,  2006;;  Beutler  et  al.,  2007;;  
Medzhitov  et  al.,  2007).  PRRs  sense  pathogens  associated  with  molecular  patterns:  DNA,  
single   or   double-­????????? ???? ??????????? ???? ????? ??-­triphospate   ends,   and   viral  
proteins.   Researchers   have   experimentally   explored   several   PRRs:   membrane-­bound  
Toll-­like   receptors   (TLRs)   and  C-­type   lectin   receptors,   and   cytosolic   receptors,   named  
RIG-­I   like   receptors   (RLRs),   and   Nod-­like   receptors   (NLRs).   TLRs   and   RLRs   play  
crucial  roles  in  the  induction  of  interferon  or  the  inflammatory  cytokine  response  to  viral  
infections   (Petrilli   et   al.,   2007;;   Kanneganti   et   al.,   2007).   Cytosolic   RIG-­I   receptors  
????????????????????????????????????????????????????????????????????????????????????????????
triphosphate   or   double-­stranded   RNAs.   Such   recognition   mediates   signals   through  
MAVS/IPS-­1  and  transduces  the  signal  through  NF-­kappa  B  or  IRF-­3.  This  leads  to  type  
I   interferons   and   inflammatory   cytokines   that   activate   the   innate   or   adaptive   immune  
responses.    Interferons  increase  genes  involved  in  the  dsRNA  signaling  pathway.  Double-­
stranded   RNAs   are   recognized   by   PKR   (Garcia   et   al.,   2006).   Activated   PKR  
phosphorylates   eIF2   alpha,   causing   global   translational   inhibition.   Another   signaling  
protein,  OAS,   recognizes  double-­?????????????????? ??????????????-­?????????????????s.    
RNAase   L,   bound   to   this   molecule,   is   activated   and   restricts   viral   replication   through  
viral  or  cellular  RNA  cleavage  (Clemens  et  al.,  2005).  Lastly,  RNAase  L  also  activate  a  
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MAVS-­signaling  pathway  to  increase  endogenous  double-­stranded  RNAs,  however,  this  
process  is  not  well  characterized  (Malathi  et  al.,  2007).  
Type   I   interferons,   such   as   interferon   alpha   and   interferon   beta   (IFN-­alpha   and  
beta),   convey   signal   transduction   through   a   Janus   Kinase   (Jak)   and   are   an   activator  
oftranscription  (STAT)  pathway  to  stimulate  gene  expression  (Illustration  1.2)  (reviewed  
by  Murray,  2007).  After  stimulation  with  type  I  interferons,  the  receptors  dimerize.  Jak1  
and  Tyk2   associate  with   interferon   receptors   to   phosphorylate   STAT1   on   tyrosine   701  
and  STAT2  on   tyrosine   690   (Banninger   and  Reich,  2004).  Phosphorylated  STAT1  and  
STAT2  translocate  into  the  nucleus  and  bind  to  interferon  regulatory  factor  9  (IRF9)  to  
canonically  form  IFN  stimulated  gene  factor  3  (ISGF3)  (Tsuno  et  al,  2009).  ISGF3  binds  
to   the   IFN-­stimulated   response   element   (ISRE)   present   on   the   promoters   of   interferon  
responsive  genes   and   leads   to  enhanced   transcription.  An   interferon  signal   transduction  
pathway   increases   the   expression   of   several   hundred   genes   and  postulates   the   antiviral  
state.   Several   interferon-­stimulated   genes encode   enzymes   that   have   been   extensively  
studied.  These   include  PKR,  OAS   (described  above),   and  Mx.  Mx  genes   express   large  
GTPases   related   to   dynamin   and   limit   the   broad   range   of   RNA   virus   replication  
recognizing  nucleocapsid-­like  proteins  (Martens  and  Howard,  2006;;  Haller  et  al.,  2007).  
Interferon-­stimulated  factors  lead  to  changes  in  cellular  translation,  cell  cycle  arrest,  and  
apoptosis.  The  type  I  interferons  also  activate  the  innate  immune-­cell  specific  responses  
to  promote  maturation  of  Dendritic  cells  and  up-­regulation  of  NK  cells  activities  (Nguyen  
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Illustration  1.2  Signalling  pathway  activated  by  IFN-­?/?.  The  biological  activities  of  
IFN-­?/?  are  initiated  by  binding  to  the  type  I  IFN  receptor.  This  leads  to  the  activation  of  
the  receptor-­associated  tyrosine  kinases  JAK1  and  Tyk2,  which  phosphorylate  STAT1  on  
tyrosine  701  and  STAT2  on  tyrosine  690.  Phosphorylated  STAT1  and  STAT2  interact  
strongly  with  each  other  by  recognizing  SH2  domains,  and  the  stable  STAT1?STAT2  
heterodimer  is  translocated  into  the  nucleus,  where  it  interacts  with  the  DNA-­binding  
protein  IRF-­9.  The  IRF-­9?STAT1?STAT2  heterotrimer  is  called  ISGF3  and  it  binds  to  a  
sequence  motif  (the  IFN-­stimulated  response  element  or  ISRE)  in  target  promoters  and  
brings  about  transcriptional  activation.  In  addition  to  the  phosphorylation  of  tyrosine,  
STAT1  also  requires  phosphorylation  on  serine  727  for  function.    
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et   al.,   2002).  One   important   function   of   interferon   is   to   induce   pro-­apoptotic   genes   in  
interferon-­treated  cells  which  dramatically  occur  after  detection  of  viral  PAMP  signatures  
such  as  double-­stranded  RNAs.  Several  pathways  have  been  suggested  for  how  interferon  
is  involved  in  the  induction  of  apoptosis  (reviewed  by  Clemens,  2003;;  Maher  et  al.,  2007)  
1)   interferon   induces   pro-­caspase   genes,   and   2)   PKR,   OAS,   and   p53   induced   by  
interferon   can   give   rise   to   apoptosis   after   double-­stranded   RNA   treatment   or   viral  
infection.   Nevertheless,   the   molecular   mechanisms   have   yet   to   be   fully   defined   and  
remain  undetermined.  
1.5  The  role  of  RNAi  in  the  antiviral  defense  of  mammalian  cells  
In   mammalian   cells,   transfection   with   small   interfering   RNAs   (siRNAs)  
complementary   to   the   viral   genome   efficiently   limits   viral   replication   and   protects   the  
host   from   lytic   viral   infection.   Initial   hypotheses   were   that   RNAi   may   function   as   an  
antiviral  mechanism  in  mammalian  cells.  However,  antiviral  defense  by  artificial  siRNAs  
cannot   prove   that   RNAi   is   a   naturally   occurring,   intrinsic   antiviral   response.   A  major  
question  remains  whether  mammalian  cells  are  able  to  induce  RNAi  in  response  to  long  
double  stranded  RNAs,  a  signature  viral  intermediate.  In  early  pioneering  work  on  RNAi,  
RNA   silencing   was   shown   to   be   effective   in   germ   cells   such   as   oocyte,   or  
nondifferentiated   mouse   cells,   and   mouse   embryonic   stem   cells   grown   in   cell   culture  
(Babiarz   et   al.,   2008;;   Tam   et   al.,   2008).  However,   RNAi   elicitation   from   long   double  
stranded  RNAs   is   not   effective   in   somatic   cells.   The   difference   in   capability   of   RNAi  
elicitation   between   germ   and   somatic   cells   is   also   recently   confirmed   by   in   vivo  
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transgenic   mouse   models,   using   exogenously   expressed   regulatory   RNA   with   a   long  
hairpin   structure   (Nejepinska   et   al.,   2012).   The   long,   double   stranded   hairpins   are  
robustly  processed  into  small  RNAs  in  germ  cells  and  reduce  the  expression  of  cognate  
messenger  RNA  sequences,  while  RNA  silencing  from  the  same  reporter  genes  were  not  
down   regulated   in   somatic   cells.   There   are   several   hypotheses   for   why   RNAi   has  
differing  responses  to  long  double  stranded  RNAs  in  somatic  cells.  Long  double-­stranded  
RNAs  induce  nonspecific  effects,  such  as  PKR  and  RNase  L  affect  global  control  of  gene  
expression   and   changes   in   cellular   RNA   levels.   It   is   noteworthy   that   the   interferon  
pathways  are  deficient  in  ES  cells  and  germ  cells.    
The  second  question  is  if  siRNAs  of  viral  origin  are  generated  from  virus-­infected  
mammalian  cells.  Pfeffer  et  al.,  (2005)  attempted  to  identify  viral  small  RNAs  from  cell  
lines   infected  with   a   broad   range   of   viruses,  DNA  viruses,   including  KSHV,  MHV68,  
HCMV,  as  well  as  RNA  viruses  including  YFV  and  HCV.  From  cell  lines  infected  with  
DNA   viruses,   they   found   newly   discovered  miRNAs   but   failed   to   detect   any   siRNAs.  
Researchers   including   Sullivan   group   have   recently   conducted   comprehensive   research  
for  viral  small  RNA  by  taking  advantage  of  next-­generation  sequencing  technologies  (Lin  
and  Sullivan,  2011).  Recently,  the  Cullen  group  reported  that  small  RNAs  from  DNA  or  
RNA  viruses  are  not  comparable  to  functional  siRNAs  shown  by  plants  and  invertebrates  
(Umbach  et  al.,  2010).  Other  groups  have  reported  that  some  viral-­derived  small  RNAs  
from   six   RNA   viruses   (Hepatitis   C,   Polio,   Dengue,   Vesicular   Stomatotis,   West   Nile  
viruses)   may   function   as   a   component   that   interacts   between   viruses   and   host  
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(Parameswaran   et   al.,   2010).  However,   it   is   still   unclear   that   the   generated   viral   small  
RNAs  are  RNAi  effectors,  which  are  dependent  on  the  Dicer  enzyme  for  the  process.  As  
small  RNA  production   is  partially   reduced  in  the  Dicer-­depleted  cells,  some  viral  small  
RNAs   can   be   derived   from   random   degradation   or   digestion   by   unknown   RNase.  
Therefore,  it  still  remains  to  be  determined  whether  the  small  RNAs  derived  from  viruses  
in  mammalian  cells  have  a  capacity   to   induce  antiviral  RNAi,  as   siRNAs  derived   from  
viruses  in  plants  and  invertebrates.  
The   third   question   is   whether   mammalian   viruses   express   RNA-­silencing  
suppressors.  Some  reports  show  that  mammalian  viral  proteins  can  inhibit  RNAi  activity.  
Influenza  NS1,  vaccine  virus  E3L,  Ebola  virus  VP35,  HIV-­Tat,  and  primate  foamy  virus  
(PFV)  Tas  have  been  suggested  to  work  as  mammalian  suppressors  of  gene  silencing  (Li  
et  al.,  2004;;  Haasnoot  et  al.,  2007;;  Bennasser  et  al.,  2005;;  Lecellier  et  al.,  2005).  These  
studies,   however,   were   mostly   not   conducted   in   the   context   of   infection   and   only  
involved  exogenous  over-­expression  of  proteins.  Because   it  has  been  demonstrated   that  
even  prokaryotic  dsRNA  binding  proteins  can  nonspecifically  inhibit  mammalian  RNAi  
in   the   condition   of   overexpression   (Lichner   et   al.,   2003),   it   is   uncertain   whether   these  
proteins  act  as  RSSs  during  bona   fide   infection.     There  has  been  one  experiment   in   the  
context  of  HSV-­1  virus  infection  (Wu  et  al.,  2009).  This  virus  inhibited  RNA  interference  
and   the   authors   hypothesized   that   the   viral   protein   may   inhibit   RNA   interference.  
However,   they   failed   to   prove   that   RNAi   is   blocked   by   a   protein   such   as   a   viral  
suppressor.    
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The   last   question   is   whether   endogenous   cellular   miRNAs   can   prevent   viral  
replication.  It  has  been  suggested  that  mammalian  cells  mount  cellular  miRNAs  to  inhibit  
viral   replication   where   host   miRNAs   are   imperfectly   matched   with   viral   transcripts.  
Evidence  as  part  of  this  argument  is  that  mammalian  miRNAs  are  evolutionary  conserved  
and   sequence   change   is   constrained   because   changes   in   the   seed   sequence   might  
transform  the  milieu  of  each  targetome.  Whereas,  when  the  RNA  virus  mutation  rate  is  
considered  to  be  fast,  the  cellular  defense  using  germ  line  transmitted  miRNAs  is  weak  in  
the   arms   race   between   virus   and   host,   from   the   perspective   of   viral   evolution.  
Nevertheless,  it  has  been  described  that  a  Dicer  hypomorphic  mouse  is  hyper  susceptible  
to   VSV   infection   because   of   the   loss   of   its   endogenous   cellular   miRNA,   which   is  
complementary  to  viral  transcripts  (Otsuka et al., 2007).  A  less  amount  of  Dicer  reduces  
cellular  mir-­24  and  mir-­93,  controlling  VSV  M  gene  expression.  Even  though  this  result  
proposes   the   idea   that   cellular   miRNAs   can   act   as   an   antiviral   defense,   it   has   the  
weakness  that   the  virus  is  not  a  naturally  infectious  pathogen  for  mice.     A  recent  paper  
reported  that  the  experiment  infected  with  physiologically  relevant  MCMV  herpes  virus  
was  less  infected  at  an  early  phase  of  infection  using  the  same  Dicer  hypomorph  mouse  
(Ostermann  et  al.,  2012).  The  author  claimed   that   some   interferon-­stimulated  genes  are  
????????????????????????????????????????????????????????????????????????????????????????????
interferon-­stimulated   gene,   is   regulated   by   miRNAs.   Therefore,   in   spite   of   diverse  
research   into   the   antiviral   mechanism   of   RNAi   in   mammalian   cells,   gaps   have   been  
exposed  in  the  original  hypothesis.  Unbiased,  continued  research  will  further  develop    
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how  viruses  interact  with  host  RNAi  and  open  new  questions  regarding  the  role  of  RNAi  
during  viral  infection  and  host  response  in  mammalian  cells  
1.6  Antiviral  defense  and  the  regulation  of  miRNA  activity  by  cytosolic  PARPs.      
Recent  reports  indicate  an  important  role  is  played  of  macromolecule  poly(ADP-­
ribose)   pADPr   in  DNA   damage   repair,   chromatin   remodeling,   and   transcription   in   the  
nucleus  of  eukaryotic  cells  (Schreiber  et  al.,  2006).  The  pADPr  forms  a  scaffold  to  recruit  
base  excision  repair  (BER)  factors  to  the  DNA  damage  site  and  facilitates  DNA  repair  by  
relaxing   the   chromosome   structure.  However,   Leung   et   al.,   recently   discovered   pADPr  
has   a   post-­   transcriptional   regulatory   function   in   cytoplasm   (Illustration   1.3).   Under  
stress,   cytoplasmic   PARP   complex   aggregates   around   each   other   by   poly   ADP-­
ribosylation   modification.   The   PARP   enzymes   also   modify   miRNA-­binding   proteins  
(Ago1-­4),  RNA  decay  factor  G3BP1,  and  translational  suppressor  TIA-­1.     Interestingly,  
cytoplasmic   proteins   in   stress   granules   are   poly  ADP   ribosylated   under   cellular   stress.  
The  modification  of  Argonaute   protein   results   in   a  decrease   in   global  miRNA  activity.  
Immunofluorescence   and   co-­immunoprecipitation   experiments   show   PARP5,   PARP12,  
and   PARP-­15   in   stress   granules   are   co-­localized   with   Ago2   protein.   Even   though   the  
biological   function   of   cytosolic   PARPs   has   yet   to   be   investigated,   PARP12   is   an  
interferon-­stimulated  gene   (ISG)  and  exhibits  ADP-­ribosyltransferase   activity.  Recently  
it  has  been  shown  that  the  long  isoform  of  PARP12  displays  antiviral  activity  for  a  broad  
range  of  alphaviruses  and  RNA  viruses  (Atasheva  et  al.,  2012).  PARP  13  was  originally    
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Illustration  1.3  Poly(ADP-­ribose)  regulates  stress  responses  and  miRNA  activity  in  the  
cytoplasm.  Poly(ADP-­ribose)  is  a  major  regulatory  macromolecule  in  the  nucleus,  where  
it   regulates   transcription,  chromosome  structure,   and  DNA  damage   repair.  Functions   in  
the   interphase   cytoplasm   are   less   understood.   poly(ADP-­ribose)   in   the   assembly   of  
cytoplasmic   stress   granules,   which   accumulate   RNA-­binding   proteins   that   regulate   the  
translation   and   stability   of   mRNAs   upon   stress.   poly(ADP-­ribose),   six   specific  
poly(ADP-­ribose)  polymerases,  and   two  poly(ADP-­ribose)  glycohydrolase   isoforms  are  
stress   granule   components.   A   subset   of   stress   granule   proteins,   including   microRNA-­
binding  Argonaute  family  members  Ago1-­4,  are  modified  by  poly(ADP-­ribose),  and  such  
modification  increases  upon  stress,  a  condition  when  both  miRNA-­mediated  translational  
repression   and   microRNA-­directed   mRNA   cleavage   are   relieved.   (Illustration   from  
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characterized  as  ZAP,  a  host  factor  restricting  the  retrovirus  infection  (Gao  et  al.,  2002).  
The  antiviral  activity  of  PARP  13  does  not  arise   through  auto-­polyADP-­ribosylation;;   it  
has  a  lack  of  PARP  domain  or  criticial  residue  for  the  ADP-­ribosylating  activity  (Hottiger  
et  al.,  2008).  Researchers  have  speculated  that  PARP13,  defective  of  PARP  activity,  can  
be  poly  ADP-­ribosylated  by  other  cytosolic  PARP  enzymes,  resulting  in  the  inhibition  of  
miRNA  activity.  It  has  recently  been  shown  that  PARP13.2,  the  shorter  isoform  between  
two   isoforms   of   PARP13,   binds   to  RIG-­I   in   response   to   viral   infection   and   stimulates  
type  I  interferon  and  inflammatory  cytokines  (Hayakawa  et  al.,  2011).  It  also  shows  that  
the   long   form   of   PARP13   (PARP13.1)   has   stronger   antiviral   activity   in   a   PARP-­like  
domain  (Kerns  et  al.,  2008).      
1.7  Dissertation  Objective  
RNA   interference   (RNAi)   is   an   evolutionarily   conserved   process   that   regulates  
gene  expression.  Host  cells  and  viruses  interact  in  many  ways,  including  via  miRNAs  and  
RNAi.  Viruses  from  both  the  polyoma  and  herpes  families  are  transcribed  in  the  nucleus  
and  encode  viral  miRNAs.  Several  studies  have  shown  that  some  viral  miRNAs  function  
to   regulate   host   or   viral   gene   expression,   but  what   remain   unknown   are   the  molecular  
functions  for  most  viral  miRNAs.  SV40,  a  model  polyomavirus,  encodes  a  miRNA  late  
during   infection   that   downregulates   early   viral   gene   expression   by   directing   mRNA  
RISC-­mediated   cleavage.   As   more   polyomaviruses   are   discovered   that   are   associated  
with  human  disease??????????????????????????????????????????????????????????????????????
to   uncover  whether   they   encode  miRNAs. Although the miRNA components of RNAi 
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are utilized by viruses during viral replication, RNAi also serves to actively defend 
against viral infection in invertebrate organisms. However, it is debated whether RNAi 
plays an antiviral role in mammalian cells. What is needed here is clarity regarding the 
role of RNAi as an antiviral defense in mammalian cells.   
    In  Chapters  2  and  3,  I  describe  how  human  polyomaviruses  encode  miRNAs  and  
explaine  that  they  utilize  them  to  auto-­regulate  viral  antigens.  Small  RNAs  have  already  
been  implicated  in  numerous  and  diverse  processes  including  neuronal  function,  diabetes,  
developmental   timing,   and   cancer.   Previous   studies   have   shown   that   several   diverse  
families  of  viruses  with  DNA  genomes  encode  miRNAs.  However,   the  functions  of   the  
vast  majority  of  viral-­encoded  miRNAs  are  unknown.  I  discovered  that  several  different  
members  of  the  Polyomavirus  family  encode  miRNAs,  all  with  a  common  function.  The  
Polyoma   family   is   responsible   for   several   serious   diseases   found   mostly   in  
immunocompromised  or  elderly  patients.  These  diseases  include  kidney  disease,   loss  of  
cognitive   function,   and   a   particularly  malignant   type   of   skin   cancer   called  Merkel   cell  
carcinoma.   I   applied   a   computational   miRNA   discovery   approach   to   screen   various  
members  of  the  Polyomavirus  family  for  candidate  miRNAs.  From  this  list  of  candidates,  
I  utilized  molecular  biological  techniques  to  validate  bona  fide  miRNAs  encoded  by  JCV  
(etiologic   agent  of  neural  disease),  BKV  (etiologic  agent  of  kidney  disease),  and  MCV  
(associated   agent   of   tumorigenesis).   The   BKV   and   JCV   miRNAs   share   a   common  
genomic   location  and  display  a  high  degree  of   sequence  similarity.   Interestingly,  MCV  
encodes   a  miRNA   in   a   different   genomic   region   that   shares   no   sequence   identity  with  
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JCV  or  BKV.  Despite  these  differences,  it  shows  that  the  miRNAs  from  all  three  viruses  
share  a  common  function  to  down-­regulate  early  viral  gene  expression  during  late  phases  
of  infection.  A  previous  study  showed  that  this  type  of  autoregulation  in  SV40,  a  related  
common   laboratory   model   of   Polyomavirus,   can   contribute   to   immune   evasion.  
Therefore,  blocking  the  function  of  the  identified  human  Polyomaviral  miRNAs  may  be  a  
valid  strategy  for  future  therapeutic  interventions.    
In  Chapter  4,   I  describe  how  in  mammalian  cells  RNA  interference  plays  a  role  
during  viral  replication.  Contrary  to  what  would  be  predicted  if  RNAi  were  an  antiviral  
response   in  mammalian  cells,  my  studies  show  that  RNAi   is  strongly   inhibited  at  early  
time  points  after  viral   infection.  Studies  with  a  chemical  mimic  of  viral   infection  (poly  
I:C)  suggest  that  the  innate  cellular  immune  response  is  responsible  for  this  inhibition.  I  
described   the   molecular   changes   (e.g.   polyADP-­ribosylation   of   Ago2)   in   the   RNA-­
induced   silencing   complex   (RISC)   in   response   to   viral   infection.   I   determined   which  
components   of   the   innate   response   affect   the   inhibition   of   RNAi.   Furthermore,   I  
proposed   that   inactivation   of   RNA   interference   promotes   the   expression   of   interferon-­
stimulated   genes.   Specifically,   miR-­17   increases   the   infectivity   of   HSV-­1,   muting   the  
interferon  response  genes  induced  by  type  I  interferon.  I  experimentally  show  that  an  ISG  
can  be  regulated  by  miR-­17/93  and  one  ISG,  IRF9,  is  derepressed  by  a  trigger  from  the  
antiviral  response.  
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            Chapter  2:  Evolutionarily  conserved  function  of  a  viral  miRNA  
2.1  INTRODUCTION  
MicroRNAs   (miRNAs)   are   small,  ?22-­nucleotide  RNA  molecules   that   regulate  
gene  expression  (Bartel,  2004).  miRNAs  bind  to  an  mRNA  and  can  repress  translation  or  
direct   the   cleavage   of   the   target   mRNA   as   part   of   the   multiprotein   RNA-­induced  
silencing  complex  (RISC).  The  so-­?????????????????????????????????????????????????????????
miRNAs)   plays   an   important   role   in   target   selection   by   RISC-­bound   miRNAs  
(Fillipowicz  et  al.,  2008).  Host-­encoded  miRNAs  have  been  shown  previously  to  play  a  
role  in  processes  relevant  to  viral  infection,  such  as  apoptosis  and  the  adaptive  and  innate  
immune  responses  (Lodish  et  al.,  2008).  Additionally,  members  of  several  virus  families  
have   been   reported   to   encode  miRNAs   (Cullen,   2006;;  Grey   et   al.,   2008;;   Peffer   et   al.,  
2003;;  Samols  et  al.,2006;;  Sarnow  et  al.,2006;;  Sullivan  and  Ganem,  2005).  Activities  have  
been  ascribed   to   a   few  such  miRNAs;;  however,   the   functions  of   the  majority  of  virus-­
encoded  miRNAs  remain  poorly  understood.    
We   have   shown   previously   that   the   monkey   polyomavirus   simian   virus   40   (SV40)  
encodes  a  pre-­miRNA  late  during  infection  that  is  processed  into  two  miRNAs  (Sullivan  
et   al.,   2005).  Both  SV40-­encoded  miRNAs   function   to   downregulate   the   expression   of  
the   viral   early   genes   by   directing   their   RISC-­mediated   cleavage.   The   two   human  
polyomaviruses   JC   virus   (JCV)   and   BK   virus   (BKV)   cause   significant   morbidity   and  
mortality  in  immunosuppressed  patients  (Berger,  2007).  JCV  is  the  causative  agent  of  a  
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fatal   central   nervous   system   demyelinating   disease,   progressive   multifocal  
leukoencephalopathy   (PML).   BKV   is   the   causative   agent   of   polyomavirus-­associated  
nephropathy   in   renal   transplant  patients.  Currently,   there  are  no  drugs   that  are  effective  
against   polyomaviral   infection.   In   this   report,   we   now   show   that   the   human  
polyomaviruses   BKV   and   JCV   also   encode   miRNAs.   Interestingly,   results   from   fine-­
mapping   studies   show   that   the   JCV  and  BKV  miRNAs   contain  multiple   differences   in  
their  seed  sequences  compared  to  the  seed  sequences  of  the  SV40  miRNAs.  Despite  this  
finding,  these  miRNAs  show  similarities  to  the  SV40  miRNAs  in  processing  and  share  a  
conserved   autoregulatory   function   with   the   SV40   miRNAs.   The   evolutionary  
implications  of  this  finding  are  discussed  below.    
2.2  RESULTS  
2.2.1  JCV  and  BKV  encode  miRNAs  homologous  to  SV40  miRNAs.  
Previously,  using  the  viral  miRNA  prediction  software  vMir,  we  predicted  that  JCV  and  
BKV   would   encode   pre-­miRNAs   homologous   to   SV40   pre-­miRNA   (Sullivan   et   al.,  
2005).  However,  given  the  high  false-­positive  rate  of  vMir  and  the  fact  that  the  predicted  
candidates   were   only   ?65%   identical,   it   was   unclear   if   these   predictions   were   valid  
(Grunhoff   et   al.,   2006).  We   utilized   a   newer   version   of   vMir   (Grundhoff   et   al.,   2006;;  
Sullivan  and  Grundhoff,  2007)  to  examine  the  JCV  and  BKV  genomes  for  candidate  pre-­
miRNAs.   This   analysis   identified   four   and   two   candidates   for   the   BKV   and   JCV  
genomes,  respectively  (data  not  shown).  Next,  we  looked  for  the  possible  derivatives  
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Figure  2.1  JCV  and  BKV  encode  miRNAs  homologous  to  the  SV40  miRNAs.  (A  to  C)  
Northern  blot  analyses  of  the  JCV  and  BKV  miRNAs.  (A)  Diagram  of  probes  used.  (B)  
JCV  miRNAs.  (C)  BKV  miRNAs.  The  arrows  indicate  the  bands  corresponding  to  the  
miRNAs.  Ethidium  bromide  staining  of  the  low-­molecular-­weight  RNA  is  shown  as  a  
loading  control.  Mock,  uninfected.  hpi,  hours  postinfection.  (D)  Alignment  of  the  BKV  
and  JCV  5p  and  3p  miRNAs  with  those  of  SV40.  The  5p  and  3p  miRNAs  are  aligned  
with  asterisks  marking  the  conserved  nucleotides.  Note  that  the  seed  region  (boxed;;  
nucleotides  2  to  8),  which  is  essential  for  target  recognition,  is  not  conserved.  Nucleotides  
that  differ  among  the  SEED  sequences  are  in  bold.  
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from  each  predicted  pre-­miRNA  via  Northern  blot  analysis.  Individual  5p  and  3p  probes  
were  generated  for  each  candidate,  and  Northern  blot  analysis  was  conducted  (Figure  2.  
1A).   Only   those   candidates   that   showed   sequence   identity   to   SV40   miRNAs   scored  
positive,  and  similar  to  SV40  miRNAs,  these  candidates  were  easily  detected  only  at  late  
times   postinfection   (Figure   2.1B   and   C;;   also   data   not   shown).   Notably,   for   all   three  
viruses,   both   arms   of   the   pre-­miRNA   are   processed   into   detectable   miRNAs.  
Interestingly,  like  SV40,    
JCV   and   BKV   each   have   a   readily   detectable   band   corresponding   to   the   pre-­miRNA.  
This   results   in   a   relatively   higher   ratio   of   the  ?60-­nucleotide   pre-­miRNA   band   to   the  
processed  ?22-­nucleotide  miRNA  band  than  is  detected  for  most  cellular  miRNAs  (Fig.  
2.1B  and  C)  (Sullivan  et  al.,  2005).  Taken  together,   these  results  suggest   that  both  JCV  
and  BKV  encode  pre-­miRNAs  with  notable  similarities  to  SV40  pre-­miRNA.    
To  map  the  derivative  miRNAs  with  more  precision,  we  generated  a  small  RNA  library  
from   cells   infected   with   either   virus.   To   do   this,   we   utilized   a   modified   protocol   of  
Pfeffer   et   al.   (2003).   PCR   primers   specific   to   each   arm   of   the   vMir-­predicted   pre-­
???????????? ????? ??? ????????????????? ???? ??? ???? ??? ????? ??? ???? ??? ???? ??????????
encoded  by  JCV  and  BKV.  The  results  from  these  mapping  studies  showed  some  but  not  
perfect  nucleotide  identity  between  the  SV40  and  BKV  and  JCV  miRNAs.  Importantly,  
both  the  5p  and  3p  miRNAs  from  JCV  and  BKV  have  several  nucleotide  differences  in  
their  seed  sequences  compared  to  the  SV40  miRNAs  (Figure  2.1D),  suggesting  different  
binding  sites  in  their  respective  targets.    
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Figure  2.2  ???????????????????????????????????????? ????????????????????????????????
cleavage  of  the  early  mRNAs.  A  modified  RACE  protocol  was  utilized  to  screen  for  
miRNA-­mediated  cleavage  fragments.  Portions  of  the  early  RNAs  corresponding  to  the  
coding  regions  for  ???????????????????????????????????????????????????????????????????????
ends  of  the  cleavage  fragments  are  denoted  with  black  arrowheads,  and  the  numbers  of  
????????????????????????????????????????????????????????????????????????????????????
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2.2.2  JCV  and  BKV  miRNAs  direct  the  cleavage  of  the  early  viral  transcripts.  
Since   the   5p   and   3p  miRNAs   are   perfectly   complementary   to   early  mRNAs,   we   next  
examined  whether  they  direct  the  cleavage  of  the  early  RNAs  in  a  small  interfering  RNA-­
?????????????? ????????????????????????????????????Llave  et  al.,  2002;;  Mansfield  et  al.,  
2004;;  Yekta  et  al.,  2004)  to  look  for  miRNA-­mediated  cleavage  fragments.  This  analysis  
showed   that,   indeed,   all   four   miRNAs   direct   the   cleavage   of   their   respective  
????????????????????????????????????????????????????????????????????????????????????
(22  of  24)  were  complementary  to  the  middle  of  an  miRNA  we  identified  (Figure  2.  2).  
Notably,  for  both  JCV  and  BKV,  more  cleavage  fragments  mapped  to  the  middle  of  the  
5p  miRNA  than  to  the  3p  miRNA.  This  result  is  consistent  with  our  observation  that  the  
5p  miRNAs  of  both  JCV  and  BKV  are  more  abundant  than  the  3p  miRNAs  (Figure  2.1B  
and   C).   To   our   knowledge,   the   polyomaviruses   represent   the   only   example   in   which  
different  miRNAs,  derived  from  both  arms  of  a  single  pre-­miRNA  precursor,  are  active  
on   the   same   molecular   targets   (the   early   mRNAs).   These   results   show   that   multiple  
polyomaviruses  encode  miRNAs  to  autoregulate  mRNA  levels.    
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Figure  2.3  The  JCV  miRNAs  expressed  late  during  infection  downregulate  early  protein  
levels.  (A)  A  diagram  of  a  Renilla  luciferase  reporter  containing  the  region  of  the  early  
genome  complementary  to  the  JCV  miRNAs  is  shown  (top).  The  graph  shows  luciferase  
levels  from  cells  transfected  with  the  reporter  plus  a  plasmid  expressing  the  JCV  
miRNAs  (JCmiRNAs)  or  a  negative  control  plasmid.  The  Renilla  luciferase  (Rluc)  values  
were  normalized  to  the  values  for  firefly  luciferase  (Fluc;;  cotransfection  control).  CMV,  
cytomegalovirus;;  ds  Renilla  luciferase,  double-­stranded  Renilla  luciferase  cDNA;;  4X  150  
bp  JCV  TAg,  four  copies  of  the  JCV  TAg  construct.  (B)  A  quantitative  immunoblot  
???????????????????????????????????????????????????????????????????????????????????????????
AS)  of  the  JCV  miRNAs  increased  early  protein  levels  during  infection.  Results  from  
transfection  with  an  irrelevant  control  oligonucleotide  are  also  shown.  The  data  presented  
are  the  averages  of  results  from  three  independent  experiments,  plotted  as  percentages  of  
the  protein  standards  loaded  onto  each  gel.  
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2.2.3  JCV  miRNAs  downregulate  large-­TAg  expression  late  during  infection.  
We  predicted  that  the  cleavage  of  the  early  mRNAs  late  during  infection  should  result  in  
a  decrease  in  early  protein  levels.  ?????????????????????????????????????????????????????-­O-­
methylated  antisense  oligonucleotides  complementary  to  either  the  5p  or  3p  JCV  miRNA  
by   using   a   strategy   similar   to   that   of   Vermeulen   et   al.   (2007).   To   quantitatively  
measurelarge   TAg   that   is   complementary   to   the   JCV   miRNAs   (Figure   2.3A).   As  
expected,  the  cotransfection  of  cells  with  the  reporter  and  a  plasmid  expressing  the  JCV  
pre-­miRNA   their   inhibitory   activities,   we   developed   a   luciferase-­based   reporter   assay.  
The  reporter  construct  contained  four  iterative  copies  of  a  region  of  the  genome  encoding  
the   JCV   resulted   in   a   dramatic   decrease   in   luciferase   levels,   while   no   decrease   was  
detected  with   a   control   reporter   (lacking   the   JCV  complementary   region)   (Figure   2.3A  
and  data  not   shown).  However,  when  cells  were  cotransfected  with  both   the  5p  and  3p  
inhibitors  and  the  reporter  and  JCV  miRNA  constructs,  almost  no  decrease  in  luciferase  
activity  was  observed.  Transfection  with   an   irrelevant   control  oligonucleotide  had   little  
effect   in   this   assay.   These   results   demonstrate   that   the   JCV   miRNAs   can   negatively  
regulate   the  expression  of   reporters  containing  150  nucleotides  of  complementary  early  
gene  transcripts  and  that  our  antisense  inhibitors  blocked  JCV  miRNA-­mediated  mRNA  
cleavage.  When  we  infected  cells  with  JCV  and  then  transfected  them  with  the  pooled  5p  
and  3p  antisense   inhibitors,   a  highly   reproducible,  albeit  modest,   increase   in   large-­TAg  
protein  levels  was  observable  at  late  times  postinfection  (Figure  2.3B),  when  the  miRNAs  
are  made.  These  results  demonstrate  that  the  JCV  miRNAs  downregulate  early  protein    




Figure  2.4  JCV  miRNAs  are  detected  in  the  brain  tissue  of  PML  patients.  Total  RNA  
was  harvested  from  sections  of  brain  tissue  from  patients  diagnosed  with  PML.  Northern  
blot  analyses  with  probes  specific  for  the  JCV  5p  and  the  loading-­control  let-­7  miRNAs  
are  shown.  Northern  blotting  with  a  probe  specific  for  the  loop  region  of  pre-­miRNA  
showed  that  the  JCV  miRNA  bands  detected  in  brain  tissue  were  not  degradation  
fragments.  (A)  Full-­length  blot  showing  the  detection  of  the  JCV  miRNA  and  pre-­
miRNA  with  the  5p  probe.  (B)  Diagram  of  probes  used.  (C)  Full-­length  blot  from  panel  
A,  stripped  and  reprobed  with  the  terminal  loop  (TL)-­probe.  Note  that  the  control  loop  
probe  and  the  5p  probe  both  detect  the  pre-­miRNA  but  that  only  the  5p  probe  detects  
bands  at  ?22  nucleotides.  This  pattern  rules  out  the  possibility  that  degradation  may  
account  for  the  miRNA-­specific  bands  detected.  The  miRNAs  detected  with  the  5p  probe  
are  indicated  with  black  arrows.  The  band  corresponding  to  the  pre-­miRNA  is  indicated  
with  a  gray  arrow.  Numbers  to  the  left  of  the  blots  indicate  sizes  in  nucleotides.  N,  





   34  
levels   and   that   the   antisense   inhibitors  we  designed  were   effective   at   blocking,   at   least  
partially,  the  functions  of  both  JCV  miRNAs.    
2.2.4  JCV  miRNAs  are  readily  detectable  in  brain  tissues  of  PML  patients.  
Most  viral  miRNAs  have  been  identified  by  the  infection  of  cultured  cells  in  vitro.  
To   examine  whether   the   JCV  miRNAs   are  made  during   infection   in   vivo,   postmortem  
tissue   samples   from   the   brains   of   patients   diagnosed   with   PML   were   obtained.   We  
harvested  total  RNA  and  probed  for  the  more  abundant  5p  JCV  miRNA.  Four  of  the  five  
PML   samples   were   positive   for   viral   DNA,   as   assayed   by   PCR.   Notably,   the   three  
samples   with   the   highest   levels   of   viral   DNA   (samples   4086,   2045,   and   6064)   scored  
positive  for   the  JCV  miRNA.  One  sample  (4086)  scored  almost  as  high  as  the  in  vitro-­
infected   cells   (Figure   2.4A   and   C,   compare   lanes   4086   to   lanes   JCV).   The   miRNA-­
specific  band  detected  was  unlikely  to  represent  a  degradation  fragment,  since  a  control  
probe  for  the  loop  region  of  the  pre-­miRNA  (which  corresponds  to  a  sequence  flanking  
the   miRNAs   and   therefore   should   detect   the   pre-­miRNA   band   but   not   the   processed,  
stable   ?22-­nucleotide   miRNA   band)   (Figure   2.4B)   detected   the   pre-­miRNA   band  
without  detecting  any  signal  around  ?22  nucleotides  (Figure  2.4C).  This  result  strongly  
suggests  that  there  was  no  general  enrichment  of  our  samples  with  nonspecific  cleavage  
fragments   in   the  ?22-­nucleotide   size   range   that   may   account   for   the   miRNA-­specific  
signal  we  detected.  Due   to   the   challenges   of   isolating  PML   lesions   away   from  normal  
brain   tissue,  we  believe   that  most   of   our  PML   lesion   samples  were   contaminated  with  
various   amounts   of   normal,   uninfected   tissue.   Thus,   these   results   likely   underrepresent  
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the  actual  abundance  of  this  miRNA  in  PML  lesions.  These  data  suggest  that  a  majority  
of  PML   lesions   in  which   JCV   is   actively   replicating  contain  high  enough   levels   of   the  
JCV  miRNA  to  be  detected  by  Northern  blot  analysis.  To  our  knowledge,  this  is  the  first  
report  of  a  viral  miRNA  being  detected  in  vivo  in  noncultured  human  tissue  samples.    
  
2.3  DISCUSSION  
Human   polyomaviruses   cause   serious   disease   in   immunocompromised   patients,  
and   effective   therapies   are   lacking.   We   set   out   to   explore   whether   the   human  
polyomaviruses   JCV   and   BKV   encode   miRNAs,   a   class   of   small   RNA   regulatory  
molecules   that   bind   to   and   (typically)   inactivate   target   mRNAs.   Here,   we   have  
conclusively   shown   that   homologous   pre-­miRNAs   expressed   by   JCV   and   BKV   show  
striking  similarities  to  a  pre-­miRNA  encoded  by  the  related  monkey  polyomavirus  SV40.  
JCV,  BKV,  and  SV40  encode  homologous  pre-­miRNA  hairpins,  both  arms  of  which  are  
processed   into   mature   miRNAs.   Despite   being   only  ?65%   identical   (5p   miRNAs   are  
?55%   identical,   and   3p   miRNAs   are   ?75%   identical),   all   three   pre-­miRNAs   share  
several   atypical   properties   in   terms   of   processing   and   abundance.   Significantly,   all  
produce  two  different  miRNAs,  both  of  which  regulate  early  gene  expression  at  late  times  
of  infection.  To  our  knowledge,  the  pre-­miRNAs  encoded  by  the  polyomaviruses  are  the  
only  pre-­miRNAs  known  to  produce  miRNAs  from  both  strands  of  the  precursor  hairpin  
that  are  active  on  the  same  target  (the  early  RNAs).  Few  viral  miRNAs  identified  so  far  
are  evolutionarily  conserved,  and  it  is  unclear  if  any  have  conserved  functions.  Notably,  
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???????????????????????????????????????????iRNA,  from  positions  2   to  8)   (Figure  2.1D),  
which  plays  a  crucial  role  in  determining  miRNA  target  specificity  (Lai,  2002;;  Lim  et  al.,  
2005),  is  not  conserved  between  SV40  miRNAs  and  the  human  polyomavirus  miRNAs.  
This   suggests   that   a   major   function   of   the   polyomaviral   miRNAs   is   their   conserved  
abilities   to   regulate   their   corresponding   early   RNAs,   which   necessarily   have   perfect  
complementarity  to  the  miRNAs  (including  the  seed  region)  generated  from  the  opposite  
strand.    
At   least   one   of   these   miRNAs   (from   JCV)   is   expressed   at   robust   levels   during  
pathological   infection   in   humans.   Currently,   there   are   no   effective   therapies   against  
polyomaviral   infection.   As   the   numbers   of   immunosuppressed   transplant   and   AIDS  
patients  grow,  so  does  the  need  for  antipolyomaviral  drugs.  We  have  previously  shown  in  
in  vitro  assays  that  miRNA-­mediated  autoregulation  of  early  gene  expression  can  reduce  
cytotoxic   T-­cell-­mediated   lysis   of   SV40-­infected   cells.   These   data   suggest   a  model   in  
which   the   primate   polyomaviral  miRNAs  may   function   to   evade   the   immune   response  
(Sullivan  et  al.,  2006;;  Vermulen  et  al.,  2007).  The  implications  of  this  model,  combined  
with  the  recent  successes  in  delivering  anti-­miRNA  inhibitors  directly  into  the  brains  of  
mice   (Krutzfeldt   et   al.,   2005;;   Krutzfeldt   et   al.,2007),   suggest   that   a   similar   approach  
directed  against  the  JCV  miRNAs  may  provide  a  treatment  strategy  for  PML.    
In   summary,  we  have  demonstrated   that  multiple  members  of   the  polyomavirus   family  
encode   a   pre-­miRNA   with   a   function   that   has   been   conserved   throughout   millions   of  
   37  
years  of  evolution.  This  finding  suggests  the  likelihood  that  some  miRNAs  in  other  virus  
families  may  also  have  conserved  functions.  
2.4  MATERIALS  AND  METHODS  
2.4.1  Computational  prediction  of  viral  miRNA  precursors  and  miRNA  cloning.  
We  used  a  new  version  of  vMir  (Grundoff  et  al.,  2006)  with  a  vMir  cutoff  score  of  175  to  
obtain  candidate  pre-­miRNAs  from  the  genomes  of  BKV  and  JCV  (the  genome  accession  
numbers  are  as  follows:  BKV,  NC_001538,  and  JCV,  NC_001699).  For  the  purpose  of  
JCV  miRNA  cloning,  we  made  an  miRNA  library  from  total  RNA  harvested  from  SVG  
cells  infected  with  JCV.  The  library  was  generated  utilizing  a  modified  protocol  of  
Pfeffer  et  al.  (Pfeffer  and  Voineet,  2006).  Briefly,  total  RNA  was  run  on  a  denaturing  
15%  polyacrylamide  gel,  and  small  RNAs  (approximately  10  to  40  nucleotides  in  length)  
were  isolated.  Small  RNAs  were  eluted  overnight  from  the  gel  slurries  and  ethanol  
precipitated  using  the  Megaclear  kit  (Ambion,  Austin,  TX)  according  to  the  





ribose).  Next,  cDNAs  were  synthesized  using  reverse  transcriptase  (Ambion,  Austin,  
TX),  and  the  resulting  products  were  cloned  using  a  TA  cloning  kit  (Invitrogen,  Carlsbad,  
?????????????????????????????????????????????????????????????????????????????????????
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miRNAs,  combined  with  linker-­specific  primers,  were  utilized  for  PCR  amplification.  To  
amplify  and  map  the  JCV  miRNAs,  we  performed  nested  PCRs.  Resulting  products  were  
????????????????????????????????????????????????????-­???????????????-­arm  (3p)  miRNAs.  
The  PCR  primer??????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????
JCV  5p  forward  primer,  TCTGAGA  CCTGGG  AAA;;  JCV  5p  backward  primer,  
AATCACAATGCTTTTCC;;  JCV  3p  outer  forward  primer,  
AGAGCCCAGGGTGCTTG;;  JCV  3p  inner  forward  primer,  
TGCTTGATCCATGTCCAGA;;  JCV  3p  outer  backward  primer,  
GATGGTGCCTACAGGACTCT;;  and  JCV  3p  inner  backward  primer,  
GACTCTGGACATGGATCAAG.    
2.4.2  Cell  culture,  virus  infection,  and  PML  brain  tissues.  
The  human  glial  cell  line  U87  and  the  green  monkey  kidney  cell  line  Vero  were  obtained  
from  the  American  Type  Culture  Collection  (ATCC,  Manassas,  VA)  and  grown  in  
Eagle's  minimal  essential  medium  supplemented  with  10%  fetal  bovine  serum.  Cells  
were  routinely  tested  to  ensure  that  they  were  free  of  mycoplasma  contamination.  The  
cells  were  infected  with  512  hemagglutination  units  of  JCV  (Mad-­1/SVE  delta  strain)  or  
BKV  (Dunlop  strain)  for  1  h  at  37°C  in  reduced  (2%)  serum.  Posthumous  clinical  brain  
tissue  samples  were  obtained  from  the  National  Neurological  AIDS  Bank  (NNAB;;  Los  
Angeles,  CA).  All  the  samples  came  from  pathologically  normal  brain  tissues  or  the  
brains  of  patients  diagnosed  microscopically  with  PML.  The  diagnosis  was  made  in  all  
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cases  based  on  the  presence  of  typical  histological  features  of  PML,  along  with  the  
clinical  history.  Samples  were  also  confirmed  to  be  JCV  positive  via  PCR  analysis  
utilizing  primers  that  amplified  a  region  of  the  genome  corresponding  to  a  portion  of  JCV  
VP1.  The  PCR  primers  used  were  as  follows:  VP1  gene  forward  primer,  
CCCAGCAGTGGAGAGGACT,  and  VP1  gene  backward  primer,  
CAGCATTTTTGTCTGCAACTG.    
2.4.3  RNA  isolation  and  miRNA  Northern  blotting.  
Total  RNA  was  harvested  from  cultured  cells  infected  with  BKV  or  JCV  or  from  solid  
brain  tissue  samples  by  using  RNAbee  according  to  the  manufacturer's  (TelTest  Labs)  
directions.  RNA  was  run  on  a  Tris-­borate-­EDTA-­urea-­15%  polyacrylamide  gel.  The  gel  
was  transferred  onto  a  Hybond  H+  membrane  and  probed  for  candidate  miRNAs  as  
described  previously  (Grundhoff  et  al.,  2006).  The  blot  was  probed  with  radiolabeled  
oligonucleotides  generated  with  P32-­labeled  radioactive  gamma  phosphate  and  T4  
polynucleotide  kinase  (U.S.  Biologicals,  Cleveland,  OH).  The  blot  was  first  probed  with  
the  5p  probe,  stripped  with  boiling  hot  stripping  buffer  (0.1%  sodium  dodecyl  sulfate  in  
double-­distilled  water),  and  then  probed  with  the  3p  probe,  the  internal-­loop  probe,  or  the  
control  probe  (hsa-­let-­7a).  The  probe  sequences  used  were  as  follows:  JCV  5p  probe,  
CAATCACAATGCTTTTCCCAGGTCTCAGAAGCCTCT;;  JCV  3p  probe,  
CAGAAGACTCTGGACATGGATCAAGCACTGAATCA;;  JCV  internal-­loop  probe,  
AGCACTGAATCACAATCACAAT;;  BKV  5p  probe,  
CAATCACAATGCTCTTCCCAAGTCTCAGATACTTCA;;  BKV  3p  probe,  
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ACTGAAGACTCTGGACATGGATCAAGCACTGAATCC;;  and  hsa-­let-­7a  probe,  
TGAGGTAGTAGGTTGTATAGTT.    
2.4.4  ???????????????????????????????????????????????????????????????????????  
mRNA  cleavage  fragments  from  JCV-­  and  BKV-­infected  cells  were  identified  utilizing  a  
modified  rapid  amplification  of  cDNA  ends  (RACE)  protocol  (Llave  et  al.,  2002)  with  a  
FirstChoice  RNA-­ligase-­mediated-­?????????????????????????????????????????????????
was  ligated  to  total  RNA  extracted  from  infected  cells.  Reverse  transcription  followed  by  
???????????????????????????????????????????????????????????????????-­  or  BKV-­
specific  primers.  PCR  products  were  cloned  using  the  TOPO-­TA  cloning  kit  (Invitrogen,  




CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATG;;  JCV  outer  primer,  GTAATA  
TGCAGTACATTTTAAT;;  JCV  inner  primer,  TACATTTTAATAAAGTATAAC;;  BKV  
outer  primer,  GTACATATACATTTAATAAATGC;;  and  BKV  inner  primer,  
ATTTAATAAATGCTGCTTTTG.    
2.4.5  DNA  constructs,  transfection,  and  luciferase  assay.    
All  DNA  constructs  were  confirmed  by  sequence  analysis.  The  plasmid  pCDNA3.1JCV  
miRNA,  which  expresses  JCV  miRNA,  was  generated  by  cloning  the  PCR-­amplified  
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portion  of  the  JCV  genome  into  the  BamHI/XhoI  sites  of  the  pCDNA3.1puro  expression  
vector  (Sullivan  and  Ganem,  2005).  A  plasmid  containing  the  entire  JCV  genome  (kindly  
provided  by  Mike  Imperiale,  University  of  Michigan)  served  as  the  template  to  amplify  
the  region  of  the  JCV  genome  corresponding  to  the  JCV  pre-­miRNA,  as  well  as  ?1  kb  of  
flanking  regions.  The  primers  used  were  as  follows:  JCV  miRNA  construction  forward  
primer,  CCTTGGATCCCTTCTTATAAGAGGAGGAGTAG,  and  JCV  miRNA  
construction  backward  primer,  GAGACTCGAGTTGGAAACCAAGTGTGAGGATG.    
pCDNA3.1dsRluc  and  pCDNA3.1dsFFluc,  expressing  destabilized  Renilla  luciferase  and  
firefly  luciferase  cDNAs,  were  constructed  by  PCR  amplification  of  a  luciferase  gene  
insert  generated  from  the  plasmid  templates  pGL4.84hRlucCP/Puro  (Promega;;  catalog  
no.  E7521)  and    pMSCV-­dsLuc2cp  (a  kind  gift  from  Andrei  Goga,  University  of  
California,  San  Francisco).  PCR  products  were  cloned  into  the  KpnI/XhoI  sites  of  the  
pCDNA3.1puro  expression  vector.  The  primers  used  were  as  follows:  Renilla  luciferase  
gene  forward  primer,  ATTGGTACCATGGCTTCCAAGGTGTACGACCC;;  firefly  
luciferase  gene  forward  primer,  GCTGGTACCATGGAAGATGCCAAAAACATTAAG;;  
and  shared  firefly  and  Renilla  luciferase  gene  backward  primer,  
AATCTCGAGTTAGACGTTGATCCTGGCGCTGGC.    
A  concatemerized  region  of  the  JCV  genome  corresponding  to  a  portion  of  the  large  T  
????????????????????????????????????????????????????????????????????????????????????
150-­bp  region  of  pCDNA3.1dsRluc  contains  sequences  complementary  to  those  of  the  
JCV  5p  and  3p  miRNAs,  as  well  as  additional  flanking  regions.  PCR  utilizing  primers  
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that  contain  the  nonpalindromic  BanI  restriction  enzyme  site  was  used  to  generate  
concatemers.  The  primers  used  were  as  follows:  JCV  TAg  gene  forward  primer,  
GAAGGCACCAGACCCATTCTTGACTTTCCT,  and  JCV  TAg  gene  backward  primer,  
GCACCACGGACAGATGTGAAAGTGCAGTTT.    
PCR  products  were  digested  with  BanI,  purified,  and  ligated  with  T4  DNA  ligase  (New  
England  Biolabs,  Inc.,  Beverley,  MA).  Taq  polymerase  (New  England  Biolabs,  Inc.,  
Beverley,  MA)  was  used  to  fill  in  the  overhanging  nucleotides,  and  the  resulting  products  
were  cloned  using  the  TA  cloning  kit.  Concatemers  of  the  four  copies  of  the  JCV  TAg  
construct  (pCR2.1JCVTAg)  were  selected  by  restriction  digest  analysis  and  subcloned  
into  the  XhoI/XbaI  sites  of  pCDNA3.1dsRluc  vectors.  PCR  was  used  to  generate  inserts  
to  subclone  from  the  TA  vector  pCR2.1JCVTAg  into  pcDNA3.1.  The  primers  used  were  
as  follows:  JCV  TAg  concatemer  forward  primer,  
ATGCTCGAGCGGCCGCCAGTGTGATGGATA,  and  JCV  TAg  concatemer  backward  
primer,  GCATCTAGAGTAACGGCCGCCAGTGTGCTG.    
293  cells  were  obtained  from  the  ATCC  and  cultured  in  Dulbecco's  modification  of  
Eagle's  medium  supplemented  with  10%  fetal  bovine  serum.  293  cells  were  plated  into  
12-­well  dishes  and  transfected  using  the  Lipofectamine  2000  reagent.  Cells  were  
transfected  with  the  pCDNA3.1dsRlucJCVTAg  plasmid,  as  well  as  pcDNA3.1dsFFluc  as  
a  transfection  control,  along  with  the  pCDNA3.1  JCV  miRNA  expression  vector.  
??????????????????????????????????????????????????????????????????????-­O-­methylated  
inhibitors  specific  for  the  5p  and  3p  miRNAs  (see  below)  or  an  irrelevant  control  
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oligonucleotide.  Cells  were  harvested  48  h  after  transfection  and  analyzed  via  a  dual  
luciferase  assay  system  (Dual-­Glo  luciferase  assay  system;;  catalog  no.  E2980)  according  
to  the  recommendations  of  the  manufacturer  (Promega).  The  luciferase  assay  results  were  
read  on  a  Luminoskan  Ascent  luminometer  (Thermo  Electronic  Corporation,  Milford,  
MA).  Results  are  presented  with  the  Renilla  luciferase  levels  normalized  by  the  firefly  
luciferase  levels.    
2.4.6  Antisense  oligonucleotides.  
The  modified  antisense  oligonucleotides  were  Dharmacon  products  synthesized  by  
Thermo  Fisher  Scientific  (Lafayette,  CO).  The  antisense  oligonucleotides  were  designed  
by  a  method  similar  to  that  described  by  Vermeulen  ???????????????????????-­O-­methylated  
nucleotides  (Vermeulen  et  al.,  2007).  The  primers  used  were  as  follows:  irrelevant  
control  antisense  primer,  
AGAAGAGAGAAAUCUCUUCUUGGCCACUCGGGGGGACAACACUAAUCGCC
AACAGACAUCUUCUCUUUCGAGAGAAGA;;  JCV  3p  miRNA  antisense  primer,  
AGAAGAGAGAAAUCUCUUCUCAGAAGACUCUGGACAUGGAUCAAGCACUG
AAUCACAAUCUUCUCUUUCGAGAGAAGA;;  and  JCV  5p  miRNA  antisense  primer,  
AGAAGAGAGAAAUCUCUUCUCUGAAUCACAAUCACAAUGCUUUUCCCAGG
UCUCAUCUUCUCUUUCGAGAGAAGA.    
2.4.7  Transfection  with  antisense  oligonucleotides  and  Western  blot  analysis  of  JCV-­
infected  cells.  
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Control  and  infected  cells  were  transfected  every  24  h,  throughout  the  duration  of  
??????????????????????????????????????????-­O-­methylated  oligonucleotide  (control)  or  50  
????????????-­O-­methylated  antisense  oligonucleotides  directed  at  the  JCV  3p  and  5p  
miRNA  sequences.  Transfections  were  conducted  using  Lipofectamine  2000  according  to  
the  protocol  of  the  manufacturer  (Invitrogen,  Carlsbad,  CA).  All  samples  were  collected  
?????????????????????????????????????????????????????????????????????
radioimmunoprecipitation  assay  buffer  on  ice.  Protein  concentrations  were  quantified  by  
a  Bradford  assay,  and  results  were  read  on  an  Eppendorf  biophotometer.  Fifty  
micrograms  of  protein  from  each  sample  was  analyzed  by  electrophoresis  on  a  4  to  15%  
Tris-­HCl  gel  for  1.5  h  at  30  mA,  and  the  proteins  were  transferred  overnight  onto  
nitrocellulose  membranes  at  4°C  and  20  V.  The  membranes  were  then  probed  with  an  
anti-­SV40  TAg  monoclonal  antibody,  diluted  1:1,000,  that  is  known  to  cross-­react  with  
JCV  TAg.  Bound  primary  antibody  was  detected  with  goat  anti-­mouse  horseradish  
peroxidase-­conjugated  secondary  antibody  diluted  1:20,000.  The  blots  were  then  
developed  using  the  Rodeo  sensitive  Western  blotting  kit  (U.S.  Biologicals,  Cleveland,  
OH).  Bands  were  visualized  by  chemiluminescence  on  a  ChemiDoc  XRS  system  (Bio-­
Rad,  Hercules,  CA).  Levels  of  TAg  expressed  in  each  sample  were  quantified  using  Bio-­
Rad  Quantity  One  gel  analysis  software,  and  results  were  calculated  relative  to  values  for  
a  loading  control  as  percentages  of  the  known  amount  of  protein  loaded  in  the  
standardized  controls  according  to  the  manufacturer's  directions.  The  results  are  
displayed  as  percentages  of  TAg  relative  to  multiple  protein  standards  (Kaleidoscope;;  
Bio-­Rad).    
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Chapter   3:   Merkel   cell   polyomavirus   encodes   a   microRNA   with   the  




microRNAs  (miRNAs)  are  post-­transcriptional  regulators  of  gene  expression  that  
play  a  role  in  numerous  and  diverse  cellular  processes  including  viral  infection  (reviewed  
in  (Gottwein  and  Cullen,  2008;;  Grey,  Hook,  and  Nelson,  2008;;  Nair  and  Zavolan,  2006;;  
Pfeffer,  2008;;  Samols  and  Renne,  2006;;  Sarnow  et  al.,  2006;;  Sullivan,  2008;;  Sullivan  and  
Ganem,  2005)).  Over  120  viral  miRNAs  have  been  described  from  divergent  families  of  
DNA   viruses.   A   functional   understanding   of   the   majority   of   viral   miRNAs   remains  
incomplete   or   unknown,   however   recent   studies   clearly   demonstrate   that   some   viral  
miRNAs   will   regulate   host   gene   expression,   viral   gene   expression,   or   both.   Viral  
miRNAs   that   regulate   host   transcripts   with   relevance   to   tumorigenesis   and   immune  
evasion   have   been   described.   In   addition,   diverse   viruses,   including   an   ascovirus  
(Hussain,   Taft,   and   Asgari,   2008),   and   several   members   of   the   Herpesviridae   and  
Polyomaviridae   have   been   shown   to   encode   miRNAs   that   autoregulate   viral   gene  
expression   (Gottwein   and   Cullen,   2008;;   Pfeffer,   2008).   It   has   been   hypothesized   that  
viral  miRNA-­mediated  autoregulation  of  gene  expression  contributes  to  regulation  of  the  
virus   lifecycle   including   the  maintenance   of   latency   and   activation   of   lytic   replication  
(Umbach  et  al.,  2008)  -­  the  proper  balance  of  which  is  key  to  immune  evasion  strategies.  
Therefore,   proper   functioning   of   autoregulatory   miRNAs   likely   profoundly   affects   the  
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fitness  of  some  viruses  during  natural  infection   in  vivo.  Thus,  combined  with  the  recent  
successes   in   rational-­designed  anti-­miRNA  inhibitors   (Elmen  et  al.,  2008;;  Krutzfeldt  et  
al.,  2005),   these  observations  suggest  viral  miRNAs  might  make  worthy  anti-­viral  drug  
targets.   Members   of   the   Polyomaviridae   include   the   model   laboratory   tumor   viruses  
murine  polyomavirus  (MuPyV)  and  Simian  Virus  40  (SV40),  and  the  human  pathogens  
BK  virus  (BKV)  and  JC  virus  (JCV).  We  have  previously  shown  that  multiple  members  
of   the  Polyomaviridae,   including  SV40,   JCV,  BKV,   and  MuPyV   encode  miRNAs   that  
autoregulate  early  gene  expression  at  late  times  of  infection  (Seo  et  al.,  2008;;  Sullivan  et  
al.,   2006;;   Sullivan   et   al.,   2005;;   Sullivan   et   al.,   2008).   Recently,   three   new   human  
polyomaviruses  have  been  described,   including  KI  virus   (KIV),  WU  virus   (WUV)   and  
Merkel  cell  polyomavirus  (MCV)  (Allander  et  al.,  2007;;  Feng  et  al.,  2008;;  Gaynor  et  al.,  
2007).  All  three  were  discovered  using  new  molecular-­based  technologies.  It  seems  clear  
from   these  and  other   related   technologies   that  we  are   in   for   an   avalanche  of  new  virus  
discoveries.   Many   of   these   viruses   are   being   discovered   faster   than   in   vitro   culture  
systems   can   be   developed.   Here   we   present   a   method   for   identifying   viral-­encoded  
miRNAs  that  does  not  require  an  experimental  infectious  system.  We  show  that  MCV,  a  
likely  etiologic  agent  of  human  cancer,  encodes  a  miRNA  on  the  late  strand  that  (similar  
to   other   reported   Polyomaviral   miRNAs)   has   the   potential   to   autoregulate   early   gene  
expression.   These   results   further   emphasize   an   important   role   for   miRNAs   in  
Polyomaviral  biology  and  suggest  a  possible  target  for  future  therapeutic  strategies.  
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3.2  RESULTS  
We  set  out  to  develop  an  experimental  strategy  to  identify  viral-­encoded  miRNAs  
that   does   not   require   abundant   amounts   of   infected   material.   We   chose   to   examine  
whether   MCV   encoded   a   miRNA   for   the   following   reasons:   First,   MCV   was   only  
recently   discovered   and   so   far   no   experimental   infectious   systems   have   been   reported.  
Second,   MCV   is   linked   to   human   cancer   and   is   likely   a   bona   fide   human   pathogen,  
suggesting   a   possible   need   to   develop   anti-­viral   therapeutic   targets.   Third,   because  we  
have   previously   shown   divergent   members   of   the   polyomavirus   family   (including   the  
SV40-­like   polyomaviruses   and   MuPyV)   encode   miRNAs   to   autoregulate   early   gene  
expression;;  it  seemed  probable  that  other  members  of  the  family,  including  MCV,  would  
also  encode  miRNAs  of  similar  function.  Our  strategy  is  to  computationally  predict  likely  
candidate   pre-­microRNAs   (pre-­miRNAs)   and   then   to   clone   them,   including   flanking  
sequence,   into   a   heterologous   expression   vector   under   control   of   the   cytomegalovirus  
major   early   promoter   (CMV).   These   plasmids   are   then   transiently   transfected   and  
screened  for  bona  fide  miRNA  expression  using  several  criteria  including:  Northern  blot  
analysis,  cloning  and  sequencing,  and  activity  in  chimeric  target  reporter  assays.  We  ran  
the   sequence  of  both  published  MCV   isolates   in   the  viral  miRNA  prediction   algorithm  
Vmir  (Grundhoff,  Sullivan,  and  Ganem,  2006;;  Sullivan  and  Grundhoff,  2007;;  Sullivan  et  
al.,  2005).  A  relatively  stringent  arbitrary  cutoff  score  of  200  was  used  and  we  focused  on  
transcripts  of  the  late  orientation  where  all  other  Polyomaviral  miRNAs  have  so  far  been  
identified.  Only   two  candidates  met   these  criteria   (Figure   3.1A).  One  candidate,  MR62  
was   found   near   the   origin   of   replication   and  was   predicted   for   both   the  MCC339   and  
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MCC350  isolate  genomes.  However,  this  candidate  was  discarded  because  this  region  of  
the   genome   produced   false   positive   candidates   from   several   other   members   of   the  
Polyomaviridae   (CSS,   unpublished   observations).   The   other   candidate,  MR17,  was   the  
top  scoring  Vmir  prediction  for  MCC339.  However,  due  to  three  nucleotide  substitutions  
in   the   pre-­miRNA  hairpin   region   (Figure   3.1B),  MR17  was   ranked   only   the   sixth   best  
candidate  for  MCC350.  We  nonetheless  pursued  candidate  MR17  (although  it  shared  no  
sequence  identity  with  any  other  known  pre-­miRNAs  of  viral  or  host  origin),  because  it  
did  however,  map  to  a  region  of  the  genome  we  have  previously  shown  encodes  a  pre-­
miRNA  in  MuPyV  (Sullivan  et  al.,  2008).    
  
A   portion   of   the   genome   including   candidate  MR17   and   flanking   regions   was  
cloned   from   either   the   MCC339   or   MCC350   isolates   into   an   expression   vector.   The  
resulting  plasmids  were   then  transfected  into  293T  cells.  Total  RNA  was  harvested  and  
Northern  blot  analysis  was  conducted  with  the  probes  described  in  Figure  3.2A.  The  5p  
probe   detected   2   bands   from   RNA   harvested   from   cells   transfected   with   either   the  
MCC339  or  MCC350  expression  vector.  The  slower  migrating  band  is  approximately  65  
nucleotides   (consistent   with   it   being   a   pre-­miRNA),   and   the   faster   migrating   band   is  
approximately  22  nucleotides-­  exactly  where  a  bona  fide  miRNA  should  migrate.  The  3p  
probe   detected   the   slower   ~65   nucleotide   band   and   low   amounts   of   a   ~22   nucleotide  
band.   Importantly,   no   specific   bands   were   detected   from   RNA   harvested   from   cells  
transfected  with  a  negative  control  vector  in  which  a  300  nucleotide  portion  of  MCC350  
(containing   the   pre-­miRNA   and   flanking   regions)   was   deleted.   In   addition,   a   control  
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??????????????????????? ???? ??????????????????????????? ?????????????????-­miRNA  hairpin,  
which   should   not   be   stabilized   by   the   downstream   miRNA   processing   and   effector  
machinery,  only  recognized  the  ~65  nucleotide  band.  These  results  rule  out  non-­specific  
RNA   degradation   as   a   source   of   the   22   nucleotide   band   detected   with   the   5p   probe.  
Combined,   these   results   strongly   suggest   that  multiple   isolates   of  MCV   encode   a   pre-­
miRNA   in   the   late   orientation,   of   which   both   the   5p   and   3p   arms   of   the   hairpin   are  
processed   into   miRNAs.   In   accordance   with   the   established   miRBase   precedence  
(Griffiths-­Jones,  2006)?????????????????????????????????-­mir-­???????????????-­
mir-­???????  
To  map  the  derivative  miRNAs  with  more  precision  we  generated  a  small  RNA  library  
from  cells  expressing  the  MCC350  miRNAs.  Small  RNAs  were  gel  purified  and  ligated  
to  linkers,  and  reverse  transcription  was  performed  to  generate  a  cDNA  library.  PCR  was  
then   conducted   with   primers   specific   to   each   arm   of   the   V-­mir   predicted   pre-­miRNA  
hai??????????????????????????????????????????????????????????????????????????????????????
the  3p  and  5p  miRNAs.  Notably,   the  miRNA  sequences  we  mapped  from  the  MCC350  
isolate  are  completely  conserved  with  the  MCC339  isolate.  (Figure  3.1B).  
  
We  next  sought  to  determine  if  MCV-­mir-­M1  was  a  functionally  active  miRNA.  
miRNAs  are  initially  transcribed  as  long  precursor  molecules  that  contain  a  characteristic  
~80-­100  nucleotide  hairpin   secondary   structure.  This  hairpin   is   recognized  and   excised  
by   the  nuclear  microprocessor  multi-­protein   complex   resulting   in   an  ~53-­80  nucleotide  
precursor  miRNA  (pre-­miRNA)  (reviewed  in  (Gottwein  and  Cullen,  2008)).  The  pre-­    
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Figure  3.1  Vmir  predictions  for  MCV  pre-­miRNAs.  (A)  Candidate  pre-­miRNAs  are  
indicated  for  both  the  MCC  339  and  MCC  350  isolates  (diamonds).  The  candidate  that  
scored  positive  in  both  MCC339  and  MCC350  (referred  to  as  MR17  in  the  text)  is  
marked  with  a  red  circle.  (B)  The  secondary  structure  predictions  for  MCV  precursors  are  
shown.  The  polymorphic  sites  between  MCC  350  and  MCC  339  are  shown  (bold).  The  
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  ????????????????-­miRNA  hairpin  is  incorporated  in  a  stable  manner  into  the  multi-­protein  
RNA  Induced  Silencing  Complex  (RISC).  RISC-­bound  miRNAs  can  then  bind  to  target  
miRNA  is  further  processed  by  the  cytoplasmic,  RNAse  III-­like  endonuclease  Dicer  into  
a  transient  double-­stranded  ~  22  nucleotide  intermediate.  Eventually,  a  portion  of  a  single  
mRNAs   with   perfect   or   imperfect   complementarity,   typically   resulting   in   cleavage   or  
translational  repression  of  the  targeted  mRNA.  We  have  previously  shown  that  multiple  
members  of  the  Polyomaviridae  encode  miRNAs  that  are  active  within  RISC  to  direct  the  
cleavage  of  the  complementary  early  strand  RNAs  late  during  infection  (Seo  et  al.,  2008;;  
Sullivan,  2008;;  Sullivan  et  al.,  2006;;  Sullivan  et  al.,  2005;;  Sullivan  et  al.,  2008).  Given    
that  MCV-­mir-­M1  is  encoded  on  the  late  strand,  antisense  to  the  early  transcripts  (Figure  
3.3A&B),  we  predicted  that  it  would  direct  the  cleavage  of  the  early  transcripts.  To  test  
this  hypothesis,  we  engineered   a   chimeric   luciferase   reporter   construct,   in  which  a   300  
nucleotide  portion   of   the   early   transcripts   (including   the  MCV-­mir-­M1   complementary  
????????????????????????????????????????????????????-­transfection  of   this  reporter  with  
either  the  MCC339  or  MCC350  MCV-­mir-­M1  expression  plasmids  results  in  a  dramatic  
reduction  in  luciferase  activity  (Figure  3.3C,  left  panel).  Co-­transfections  of  vector  alone,  
an   irrelevant   miRNA   (JCV),   or   a   vector   encoding   MCC350   with   the   miRNA   region  
deleted  had  no  effect  on  this  reporter  (Figure  3.3C,  left  panel)  arguing  that  the  effect  we  
observe   is   specific   to   the  MCV  miRNAs.   Importantly,   no   effect   of   the  MCV  miRNAs  
was  detected  when  they  were  co-­transfected  with  a  control  reporter  plasmid  that   lacked  
complementary  sites  to  MCV-­mir-­M1  (Figure  3.3C,  right  panel).  From  these  results,  two  
inferences  can  be  made.  First,  MCV-­mir-­M1  is  fully  active  within  RISC,  lending  further       





 Figure  3.2  The  Merkel  cell  poloymavirus  isolates  MCC  339  and  MCV  350  encodes  
miRNAs.  (A)  Diagram  of  probes  used.  Each  sample  was  assayed  with  a  probe  that  
detects  the  5p  or  3p  arm  or  terminal  loop  portion  of  the  pre-­miRNA.  (B-­D)  Northern  blot  
analysis  for  the  MCV  miRNAs.  RNA  harvested  from  cells  transfected  with  the  mock,  
negative  control  ?  MCV  miRNA,  the  MCC339  or  MCC350  miRNA  expression  vectors  
was  analyzed  with  the  indicated  probes.  Ethidium  bromide  staining  of  the  low  molecular  
weight  RNA  is  shown  as  a  loading  control.  Bands  corresponding  to  the  5p  and  3p  










Figure   3.3   The   MCV   miRNAs   downregulate   early   transcripts.   (A)   Map   of   MCV  
genomic   organization   with   the   location   of   the   5p   and   3p  miRNA   indicated   with   gray  
????????????????????????????? ?????????????????????????-­  ??????????????????????????????
????????????????????-­  ????????????????????????????????????ds  of  MCV  Large  T  Antigen  
that  correspond  to  this  region.  (C)  Diagrams  of  the  MCV  miRNA  reporter  construct  (top,  
left)  and  control  reporter  (top,  right)  are  shown.  The  vectors  consist  of  a  Renilla    
luciferase  reporter  with  or  without  a  single  copy  of  a  300  nucleotide  region  of  the  Large  T  
antigen   early   transcript   (complementary   to   the  M?????????? ??????? ????? ???? ??????  
Cells  were   transfected  with   either   reporter   plus   a   plasmid   expressing   vector   alone,   the  
MCV339   miRNA,   the   MCV350   miRNA,   the   JCV   miRNA,   or   ?   MCV   miRNA   (a  
negative  control  MCV  plasmid  in  which  the  pre-­miRNA  region  has  been  deleted).  Firefly  
luciferase   was   used   as   a   transfection   control   and   Renilla   luciferase   levels   are   plotted  
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support  as   to   the  authenticity  of   this  miRNA.  Second,  MCV-­mir-­M1  functions  to  direct  
cleavage  of  the  early  RNAs  during  MCV  infection. 
  
3.3  DISCUSSION  
The  post-­genomic  era  has  ushered  in  several  new  virus  discovery  techniques  that  
will  likely  provide  a  windfall  of  new  pathogens  in  the  near  future.  Many  of  these  viruses  
will  not  have  a  readily  available  experimental  system  making  developing  and  testing  anti-­
viral   drugs   a   challenge.  We   propose   that   one   useful   strategy  will   be   to   identify   virus-­
encoded  miRNAs   and   utilize   existing   successful   antisense   anti-­miRNA   drug   strategies  
(Elmen  et  al.,  2008;;  Krutzfeldt  et  al.,  2005)  to  develop  potential  therapeutics.  A  first  step  
to   realizing   this   goal   is   to   develop   methods   to   identify   miRNAs   encoded   by   such  
pathogens.  In  this  work,  we  describe  such  a  method  and  prove  its  utility  on  the  recently  
described  polyomavirus  MCV.  We   show   that   two  different   strains  of  MCV  encode   the  
miRNA   despite   having   a   difference   of   3   nucleotide   substitutions   in   the   pre-­miRNA  
hairpin.      Interestingly,   these   substitutions   result   in   2   non-­conservative   amino   acid  
substitutions   in   the  Large  T  antigen  protein   that   is   encoded  on   the  early   strand   (Figure  
3.3B).   However,   these   changes   do   not   significantly   alter   the   predicted   pre-­miRNA  
hairpin  secondary  structures  on   the   late  strand  (Figure  3.1B)  and   the  pre-­miRNAs  from  
both  the  MCC339  and  MCC350  isolates  have  similar  processing  efficiencies  (Figure  3.2).  
Furthermore,  the  derivative  miRNAs  from  both  the  MCC350  and  MCC339  isolates  have  
similar  activities  in  directing  the  cleavage  of   the  early  transcript   reporter   (Figure  3.3C).  
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These  results  suggest  evolutionary  pressure  exists  for  MCV  to  maintain  expression  of  the  
miRNAs.  
  
We   used   stringent   criteria   to   conclude   that  MCV-­mir-­M1   is   a   bona   fide  miRNA.   The  
miRNA  we  identified  is  detectable  via  Northern  blot  analysis  (Figure  3.2)  and  is  active  at  
directing  the  inhibition  of  reporter  gene  expression,  most  likely  through  a  RISC-­mediated  
mechanism  (Figure  3.3C).  Furthermore,  fine  mapping  studies  of  the  MCV-­mir-­M1  and  its  
cognate  *  3P  sequence  (the  strand  that  is  less  efficiently  incorporated  into  RISC)  results  
in  a  predicted  duplex  secondary  structure  with  2-­?????????????????????????-­  a  hallmark  of  
both  microprocessor  and  Dicer  processing.  Combined,  these  results  prove  MCV-­mir-­M1  
is  a  bona  fide  miRNA.  A  notable  caveat   to  our  approach  is   the  possibility  that  we  have  
missed  other  possible  bona  fide  miRNAs  encoded  by  MCV.  Indeed,  Vmir  predicted  four  
candidates  that  scored  higher  than  MR17  in  the  MCC350  genome  (Figure  3.1A).  While  
Vmir   is   a   useful   starting   point   for   identifying   novel  miRNAs   in   viral   genomes,   a   high  
Vmir   score   alone   is   relatively   uninformative   due   to   the   possibility   of   false   positives.  
Therefore,   ruling   out   the   existence   of   additional   MCV   miRNAs   is   not   possible   until  
exhaustive,  saturated  small  RNA  cloning  is  performed  on  RNA  obtained  from  all  stages  
of   the  virus  lifecycle  (e.g.  persistent  and  lytic   infection).  Obviously,   these  studies  await  
the  development  of  laboratory  models  of  MCV  infection.      
  
What   is   the   function   of   the   MCV   miRNA?   Two   lines   of   reasoning   strongly  
suggest   that  MCV-­mir-­M1   functions   to   autoregulate   early   viral   gene   expression   at   late  
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times  post  infection.  First,  every  polyomavirus  we  have  examined  in  detail,  including  the  
SV40-­like  polyomaviruses   (SV40,  JCV  and  BKV)  and  MuPyV  encode  miRNAs  at   late  
times   of   infection   that   direct   the   cleavage   of   early   RNA   acting   to   autoregulate   early  
protein   levels   at   late   times   during   infection   (Seo   et   al.,   2008;;   Sullivan   et   al.,   2006;;  
Sullivan   et   al.,   2005;;   Sullivan   et   al.,   2008).   The   genomic   location,   antisense   and  
complementary  to  the  early  RNAs,  supports  a  similar  activity  for  MCV-­mir-­M1.  Second,  
we  have  demonstrated  that  a  chimeric  reporter  containing  a  portion  of  the  early  RNAs  is  
specifically  downregulated  by  expression  of  MCV-­mir-­M1.  Importantly,  these  results  do  
not   rule   out   a   potential   additional   function   for   MCV-­mir-­M1   in   regulating   a   cellular  
target.  However,  since  MCV-­mir-­M1  shares  no  sequence   identity  with  any  of   the  other  
known  Polyomaviral  miRNAs,  it  seems  highly  unlikely  that  these  miRNAs  could  bind  to  
and   regulate   the   same   cellular   target.   Thus,   our   results   strongly   suggest   that   a   major  
function   of   the  MCV  miRNA,   similar   to   the   other   Polyomaviral   miRNAs,   will   be   to  
autoregulate  early  gene  expression  at  late  times  of  infection.  
  
Finally,   the   fact   that   the  MCV  miRNA   is   likely   only   expressed   during   lytic   infection  
(when  the  late  genes  are  expressed),  limits  the  potential  utility  of  it  as  an  anti-­viral  drug  
target.  To  date,  MCV  is  associated  with  tumorigenesis   in  cases  where  the  viral  genome  
has   integrated   into   the  host  genome   in   a   stable   fashion  and   is   likely  only  competent   to  
express  early  gene  products.  It  is  currently  unclear  if  any  of  these  tumors  are  undergoing  
active   lytic   infection.  Nonetheless,  blocking   the  MCV  miRNA  function  will  do   little   to  
inhibit  the  tumorigenic  activity  of  T  antigens  that  are  expressed  from  the  tumor  genome.    
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However,   as   the  MCV   field   is   brand   new,   it   remains   possible   that   lytic   infection  may  
indeed  one  day  be  linked  to  pathogenesis,  and  in  that  case,  MCV-­mir-­M1  is  a  plausible  
therapeutic  target.  Irrespective,  our  study  provides  a  proof  of  principle  that  viral  miRNAs  
can  rapidly  be  identified  in  newly  emerging  pathogens.  
  
3.4  MATERIALS  ANS  METHODS  
3.4.1  Computational  prediction  of  MCV  miRNA  pre-­cursors  and  miRNA  northern  
blot  analysis.    
  
Vmir  (Grundhoff,  Sullivan,  and  Ganem,  2006;;  Sullivan  and  Grundhoff,  2007;;  Sullivan  et  
al.,  2005)  was  used  to  predict  candidate  pre-­miRNAs  in  the  MCV  genome  (The  accession  
numbers  are;;  MCC350:  EU_375803,  MCC339:EU_375804).  The  candidates  were  cloned  
into  pcDNA3.1  puro,   transiently   transfected   into  human  embryonic  kidney  cells   (HEK)  
293T.  Total  RNA  was  harvested  using  an  in  house  Trizol-­like  reagent  (2M  Guanidinium  
Thiocyanate,  20mM  Citrate  buffer  (PH  4.5),  5Mm  EDTA,  0.25%  Sarkosy,  48%  saturated  
phenol   (PH   4.5),   2.1%   isoamyl   alchol,   0.5%   beta-­mercaptoethanol,   0.1%   8-­
Hydroxyquioline,  0.0025%  Coomassie  blue)  and  Northern  blot  analysis  was  conducted  as  
previously  described  (Seo  et  al.,  2008)  using  the  following  probes:  
????????????????????????????????????????????????  
?????????????????????????????????????????????????  
MCV  loop:  CACACCCAATGGAACCAGTGTAC  
  
3.4.2  Small  RNA  library  generations  and  fine  mapping  of  MCV  miRNA.  
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For  fine  mapping  of  the  MCV  miRNA,  a  library  was  generated  as  previously  described  
(Seo   et   al.,   2008).   Briefly,   small   RNA   (10   -­40   nucleotides)   was   harvested   from   293T  
cells   transfected   with   the   MCC350   miRNA   expression   plasmid.   The   small   RNA   was  
ligated   and   TA   cloned   into   PCR2.1.   miRNA   specific   primers   were   used   in   a   PCR  
???????????? ?????????????????????????????????? ??? ?????????????????????????????  
  
5?  linker  forward  primer:  GTTGATCAGAGCCCAGGG;;    
??????????????????????????????????????????????  
MCV  5p  forward  primer:  AGTGTACCTAGAAATTCC  
MCV  5p  backward  primer:  GTTCTGGAAGAATTTCTA    
MCV  3p  forward  primer:  ATTCAGGAAGAGAATCCA  
MCV3p  backward  primer:  GTGTGCTGGATTCTCTTC  
  
  
3.4.3  DNA  constructs,  transfection  and  Luciferase  assays.    
  
All  DNA  constructs  were  confirmed  by  sequence  analysis.  pCDNA3.1MCVmiRNA  
(MCC350),  that  expresses  the  MCV  miRNAs,  was  generated  by  subcloning  into  the  Hind  
III/Xba  I  sites  of  pCDNA3.1puro  expression  vector  (Sullivan  and  Ganem,  2005).  A  
plasmid  containing  the  entire  MCV  genome  (kindly  provided  by  Drs.  Chang  and  Moore,  
University  of  Pittsburgh)  served  as  template  to  subclone  the  region  of  the  MCV  genome  
containing  the  MCV  pre-­miRNA  as  well  as  ~1Kb  of  flanking  regions.  The  resulting  
?????????????????????????????????????????????????????????????? ??????
miRNA  expression  vector  ,  we  conducted  PCR  mutagenesis  using  
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pcDNA3.1puroMCV350miRNA  as  the  template.  As  a  negative  control,  we  engineered  a  
deleted  version  of  pcDNA3.1puroMCV350miRNA  in  which  300  nucleotides  of  
sequence,  encompassing  the  pre-­miRNA  and  surrounding  regions  (nts  1017-­1318  of  the  
MCC350)  was  deleted.  The  luciferase  reporter  assays  were  performed  as  previously  
described  (Seo  et  al.,  2008)  in  HEK  293  cells.  The  reporter  contains  a  single  copy  of  a  
300  nucleotide  sequence  (1051-­1350  nt  positions  from  one  of  the  MCC  genomes  
MCC350)  corresponding  to  the  complementary  and  flanking  regions  of  the  early  
transcripts.  As  a  transfection  control,  Renilla  luciferase  levels  were  normalized  to  a  co-­
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RNA   interference   is   an   evolutionarily   conserved   process   to   direct   post-­
transcriptional   regulation   of   gene   expression   by   small   RNAs.   These   small   RNAs   can  
enter  a  protein  complex  (RISC)  that  binds  directly  to  mRNA  targets  resulting  in  specific  
inhibition  of  translation.  Small  RNAs  and  RNAi  are  important  modulators  during  virus-­
host  interactions  (Umbach  and  Cullen,  2009;;  Sullivan,  2008).  While the role of RNAi as 
an antiviral defense is well established in plants and invertebrates, it is still a hotly-
debated issue in mammalian systems (Umbach and Cullen, 2009;  Van  Rjj   et   al.,   2006;;  
Ding  and  Voinnet,  2007). Artificial   transfection  with   small   interfering  RNAs   (siRNAs)  
complementary   to  viral   genome  efficiently   limits   the  viral   replication  and  protects  host  
from  lytic  viral  infection.  However,  it  is  not  enough  to  prove  that  the  RNAi  is  a  natural  
intrinsic  antiviral  response.  Some  reports  show  that  mammalian  viral  proteins  can  inhibit  
RNAi  activity  (Haasnoot  et  al.,  2007;;  Lichner    et  al.,  2003).  However,  these  studies  were  
not  conducted  in  the  context  of  infection  and  only  involved  exogenous  over-­expression  of  
the   proteins.  Another   study   shows   that   knocking-­out   a  RNAi  machinery   component   in  
mammalian   cells   increases   the   replication   of   a   specific   virus   because   of   the   loss   of  
endogenous   cellular   miRNA,   which   is   fortuitously   complementary   to   viral   transcripts  
(Otsuka   et   al.,   2007).   To   date,   no   viral   specific   siRNAs   have   been   detected   in   studies  
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conducted  by  small  RNA  cloning  or  in  deep  sequencing  of  mammalian  cells  while  small  
siRNAs  associated  with  the  antiviral  response  are  readily  detectable  in  plants  and  insects  
during  infection  (Ding  and  Voinnet,  2007).  
DNA   viruses   make   long   double   stranded   RNA   by   overlapping   transcription.  
RNA   virus   also   produces   double   stranded   RNAs   during   virus   life   cycle.   RNA  
interference   pathway   elicits   the   production   of   virus-­derived   small   interfering   RNAs  
(viRNAs)   and   induces   specific   gene   silencing   by   viRNA-­RNAi   effector   complexes.  
miRNAs   are   another   classes   of   small   RNAs.   The   mature   22   nucleotide   products   are  
finally   incorporated   into   the  RNA?induced  silencing  (RISC)  complex.  The  functions  of  
miRNAs  depend  on   the   complementarities   between  miRNA  and   the   target  mRNA  site  
(Kim  et  al,  2009).  While  miRNAs  function  to  regulate  gene  expression  for  development  
and  cell  homeostatsis,  it  is  not  well  characterized  whether  it  controls  endogenous  innate  
immune  response  genes,  specially  interferon  stimulated  genes.  
In  mammalian  cells,  interferon  production  is  a  primary  defense  response  to  viral  infection  
(Randall  and  Goodbourn,  2008).    Interferon  induction  is  initiated  by  cytoplasmic  pattern  
recognition   receptors   (PRR).   PRRs   such   as   MDA5   and   RIG   I   sense   a   viral   double  
stranded  RNA  structure   in   a   size   and  structure  dependent  manner   (???????? ???????????
2009),  typically  as  an  intermediate  during  viral  replication.  Such  recognition  transducers  
signal   through  the  common  molecule  MAVS/IPS-­1  and  amplify  the  signal   through  NF-­
kappaB   or   IRF-­3   leading   to   interferon   production.   Double   stranded   RNAs   are   also  
recognized   by   PKR.   Activated   PKR   phosphorylates   eIF2   alpha,   causing   global  
translational   inhibition.   Lastly,   RNAase   L   pathways   also   activate   a   MAVS-­signaling  
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pathway,  increasing  endogenous  double-­stranded  RNAs,  which  are  not  well  characterized  
(Malathi  K,  2007).    
It  has   recently  been  shown  how  ????????????????? ??? ?????????? ????????????????
cellular   stress.   Leung   et   al.,(2011)   discovered   pADPr   has   new   post-­transcriptional  
regulatory   function   by   inhibiting   miRNA   activity   in   cytoplasm.   Macromolecule,  
poly(ADP-­ribose)  pADPr,  has  been  reported  to  play  an  important  role  in  DNA  damage  
repair,  chromatin  remodeling,  and  transcription  in  nucleus  of  eukaryotic  cells.  However,  
cytoplasmic  PARP  complex  aggregate  each  other  by  poly  ADP-­ribosylation  modification  
under  cellular  stress.   Interestingly,  cytoplasmic  proteins   in  stress  granule  are  poly  ADP  
ribosylated   in   response   to   cellular   stress   and   the   modification   of   Argonaute   protein  
results  in  the  decrease  of  global  miRNA  activity.  Even  though  the  biological  function  of  
cytosolic   PARPs   remains   to   be   investigated,   PARP12   is   one   of   interferon   stimulated  
genes  (ISGs),  it  has  an  ADP-­ribosyltransferase  activity.  Recently  it  reveals  that  the  long  
isoform  of  PARP12  has  an  antiviral  activity  for  the  broad  range  of  alphaviruses  and  RNA  
viruses.   PARP   13   was   originally   characterized   as   ZAP,   a   host   factor   restricting   the  
retrovirus  infection.  It  is  speculated  that  PARP13,  defective  of  PARP  activity,  poly  ADP-­
ribosylated   by   other   cytosolic   PARP   enzyme   and   results   in   the   inhibition   of   miRNA  
silencing.   It   recently   has   been   shown   that   PARP13.2,   shorter   isoform   among   two  
isoforms  of  PARP13,  binds  to  RIG-­I  in  response  to  viral  infection  and  stimulates  type  I  
interferon   and   inflammatory   cytokines.   It   also   shows   that   long   form   of   PARP13  
(PARP13.1)  has  a  stronger  antiviral  activity  by  PARP  like  domain.        
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       For  this  study,  I  established  cell  based  reporter  assay  to  monitor  RNAi  activity  in  
293   cells   to   determine   whether   RNAi   plays   an   antiviral   role   in   mammalian   cells.   
Contrary to what would be predicted if RNAi is an antiviral response in mammalian 
cells, it shows that RNAi is strongly inhibited at early time points after viral infection. 
Studies with a chemical mimic of viral infection (poly I:C) implicate that the innate 
cellular immune response is responsible for this inhibition. This study describes a 
previously unknown mechanism that the depression of RNAi is caused by the host innate 
immune response and poly ADP ribosylation in mammalian cells.  
  
4.2  Result  
4.2.1  Triggering  of  the  antiviral  response  blocks  RNAi.  
It   is   unclear   how   RNAi   activity   is   modulated   in   response   to   viral   infection   in  
mammalian  cells.  There  is  no  convincing  data  showing  that  RNAi  plays  a  crucial  role  in  
host  defense  in  response  to  viral  infection  in  mammalian  cells.  I  generated  reporter  cell  
lines  to  monitor  RNAi  activity  (Figure  4.1)  to  test  the  idea  that  RNAi  may  only  be  active  
against   viral   infection   in   mammalian   cells   under   conditions   in   which   the   host   cell   is  
undergoing   an   anti-­viral   response.   (Note:   the   antiviral   response   changes   numerous  
signaling   pathways   and   dramatically   alters   cellular   physiology).   I   generated   stable   cell  
lines   expressing   destabilized   renilla   luciferase   reporters   containing   4   copies   of   viral  
miRNA   binding   sites   (Figure   4.1A).   Stable   cell   lines   that   also   express   an   exogenous  
miRNA   that   ???????? ???? ??????????? ????????? ????? ?????? ????? ????? ???? ???????? ???????????
activity  was  reduced,  and  the  mRNA  level  of  renilla  luciferase  was  less    
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Figure  4.1  A  trigger  of  antiviral  response  inhibits  RNA  interference  (RNAi).    
  (A)Mother  cell  line  (Mo)  expresses  both  a  Renilla  Luciferase  (Ren  Luc)  and  a  Firefly        
              Luciferase  (FF  Luc)  construct.  JM1  and  JM19  cells  are  derived  from  Mo  cells  and        
              express  an  exogenous  JCV  viral  miRNA  that  directs  RNAi  repression  against        
              Ren  Luc.  Transfection  of  an  Anti-­miR  de-­represses  RNAi  (grey  bars  transfected    
              with  specific  JCV  Anti-­miR).  Northern  blot  analysis  shows  depression  of  RNAi    
              occurs  at  the  level  of  RNA.    
(B)  Dual  luciferase  activity  assay  using  parental  cell  (Mo)  or  microRNA  reporter  cell    
            (JM1).  Mo      or  JM1  cells  were  transfected  with  0.5µg  pI:C,  a  potent  activator  of  the        
            antiviral  response.  Luciferase  activity  was  measured  at  indicated  time.  The    
          depression  of  the  RNAi  reporter  is  only  observed  in  JM1  cells.  To  obtain  the  relative    
          fold  repression,  the  luciferase  activity  (RL/FL)  in  pI:C  treated  cells  was  normalized    
          to  the  luciferase  activity  (RL/FL)  of    untreated  cells.  Northern  blot  analysis  of  JM1    
          cells  treated  with  pI:C.  Note  the  cleaved  18S  rRNA,  indicative  of  RNaseL  activity    
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expressed   compared   to   control   cell   lines  which   only   contain   reporters  without  miRNA  
expression  (Figure  4.1A).  To  confirm  that   the  reduced  RNAi  activity   is  due   to  miRNA  
?????????? ?? ???????????? ???? ????????? ????? ?????? ????? ??-­O-­   methylated   oligonucleotides  
(control   and   viral   miRNA   specific   Anti-­miR).   The   antisense   inhibitor   increased   the  
luciferase  activity  and  renilla  luciferase  mRNA  level  of  reporter  cell  lines.  Additionally,  I  
transfected   poly   I:C   (a   viral   dsRNA   mimic),   to   trigger   the   antiviral   response   in   the  
absence   of   viral   gene   expression   (Figure   4.1B).   All   treatments   described   resulted   in  
inhibition  of  RNAi  .  These  surprising  results  oppose  our  original  hypothesis  and  suggest  
that  mammalian   cells   turn   off   the   RNAi   response   upon   sensing   viral   infection.   These  
findings  have  important  implications  as  to  the  contentious  debate  of  whether  or  not  RNAi  
can  serve  as  an  antiviral  process  in  mammalian  cells.  
  
4.2.2  Antiviral-­mediated  De-­repression  of  RNAi  occurs  post-­dicer  
To   consider   what   component   of   the   RNAi   machinery   is   affected   by   the   antiviral  
response,   I   determined   the   steady   state   level   of   miRNA   in   reporter   cell   lines   (Figure  
4.2A).   I   performed  miRNA  Northern   blot   analysis   on  RNA   harvested   from   the  RNAi  
reporter  cells  under  normal  conditions  and  from  cells  treated  with  poly  I:C.  I  probed  for  
the   two  viral  miRNAs  as   two  exogenous  miRNAs   target   reporters.  The   steady   level  of  
miRNA  was  equal  in  both  poly  I:C  treated  and  untreated  cells.  Furthermore,  endogenous  
cellular   miRNAs   (hsa-­LET-­7)   were   detected   in   identical   levels   in   both   cells.   This  
demonstrates    
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4.2.3  RISC  mediated  cleavage  inhibited  by  poly  I:C    
  
As  RISC  functions  downstream  of  Dicer,  I  performed  an  experiment  to  determine  
if  RISC  activity  is  inhibited  by  antiviral  signaling.  I  adapted  the   in  vitro  Ago2  cleavage  
assay  used  in  Zebrafish  system  to  mammalian  cells.  I  applied   in  vitro  RISC  assay  using  
purified   pre-­mir   451   (Dharmacon),   which   has   a   process   of   Ago2   specific   cleavage  
bypassing  dicer  step  in  the  miRNA  biogenesis  (Cheloufi et  al.,  2010).  Treatment  of  Ago2  
substrate  RNA  with  mammalian  cell  lysate  results  in  specific  cleavage.  Immunodepletion  
assay   of   Ago2   confirms   the   specificity   of   this   assay.   Lysate   prepared   from   cells  
transfected  with   poly   IC   is   defective   in   RISC   ?  mediated   cleavage   demonstrating   that  
RISC  is  blocked  by  antiviral  signaling  (Figure  4.2B).  
  
4.2.4  Triggering  the  anti-­viral  response  ADP-­ribosylates  Ago2  
As  RISC  activity  is  changed  by  antiviral  response,  viral  stresses  will  change  the  
modification   of   the   Ago2.   Such   modification   will   affect   the   RISC   activity.   Recently,  
Leung  and  colleagues   (2011)  demonstrated   that   treatment  of   cells  with  oxidative  stress  
and  inhibition  of  translation  by  drug  induced  pADP-­R  of  human  Ago1-­4  which  relieves  
miRNA-­mediated   repression.   Immunoprecipititiaon   of   Ago2   followed   by   immunoblot  
with   antibody   that   detects   pADP-­R   modified   proteins   of   Ago2   in   the   pI:C   treated  
samples.   Performing   RNAi   activity   assay   in   the   presence   of   a   chemical   inhibitor   of  
PARP  [3-­aminobenzamide]  results  in  a  diminished  relief  of  RNAi  that  is  triggered  by    
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Figure  4.2    A  trigger  of  antiviral  response  inhibits  in  vitro  RISC  mediated  cleavage  and  
RNAi  through  poly  ADPribosylation.  
(A) The  antiviral  response  inhibits  RNAi  at  the  level  of  RISC.  Northern  blots  analysis  
shows    miRNA  levels  are  unaffected  by  pI:C  treatment.  Equal  amount  of  a  viral  
miRNA  that  directs  RNAi  against  Ren  Luc  from  pI:C  treated  and  untreated  cells  
was  detected  and  a  endogenous  cellular  miRNA  (hsa  let-­7  miR)  also  had  similar  
levels  in  pI:C  treated  and  untreated  cells.    
(B)   pI:C  inhibits  RISC  mediated  cleavage.  To  validate  the  Ago2  specific  cleavage  of      
substrate  in  an  in  vitro  RISC  mediated  cleavage  assay,  Ago2  was  immunodepleted  
with  a  Ago2  polyclonal  antibody  (7C3)  or  IgG  and  supernatant  was  added  into  the  
assay.  Crude  extracts  from  pI:C  treated  or  untreated  cells  were  used  in  the  in  vitro  
????? ???????????????????????????????????  radiolabled  substrate  (gel  purified  pre-­
miR  451).    The  cleavage  product  of  pre-­miR451  was  not  shown  in  Ago2  
immunodepleted  or  pI:C  treated  sample.  The  cytosolic  protein  amount  used  in  in  
vitro  ???????????????????????????????? ??????????? ???????-­Actin.  
(C) Antiviral  triggers  result  in  the  poly  ADP-­ribosylation  of  Ago2.  HEK  293  cells  were  
treated  with  pI:C.  Immunoprecipitated  Ago2  from  whole  cell  lysates  were  analysed  
by  western    blot  with  an  antibody  specifically  detecting  poly(ADP)-­ribose.  A  90min  
treatment  with  250µM    Sodium  arsenite  served  as  a  poistive  control  of  Ago2  poly  
ADP-­ribosylation  (Leung  ak  et  al,  2011).  Equal  amount  of  Ago2  IP  was  measured  
by  Ago2  antibody.    
(D) Treatment  with  3-­aminobenzamide  (a  PARP  inhibitor)  blocks  pI:C-­mediated    
inhibition  of  RNAi.  JM1  reporter  cell  lines  were  transfected  with  0.5  µg  pI:C.  
RNAi  activity  was  measured  after  treatment  with  20  mM  3-­aminobenzamide.  
(E) The  knockdown  of  PARP13  mitigates  the  inhibition  of  miRNA  activity  after  
treatment  with  pI:C.  JM1  reporter  cells  were  transfected  with  an  siRNA  against  
eGFP  or  PARP13.  Relative  fold  repression  was  measured  as  the  activity  of  
luciferase  (RL/FL)  in  the  pI:C  treated  cells  normalized  to  untreated  cells.  The  
relative  fold  repression  by  JCV  Anti-­miR  was  shown  as  maximized  fold  repression.  
The  experiment  independently  repeated  more  than  three  times.  This  is    a  
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that   the  miRNA  maturation  was  not  changed   in  cells  undergoing  the  antiviral  response.  
Therefore,   it   suggests   that   RISC,   downstream   of   Dicer,   must   be   regulated   to   inhibit  
RNAi   activity   in   response   to   viral   infection.   Triggers   of   the   antiviral   response,  
specifically   poly   I:C,   activate   PKR   and   lead   to   nonspecific   translational   inhibition   by  
phosphorylating   eIF-­2   alpha   (Randall   and   Goodbourn   2008).   I   determined   whether  
triggers  of  the  antiviral  response  alter  the  amounts  of  RISC  components.  Ago2  proteins  
are  major  protein  in  RISC  complex  and  Dicer  protein,  RNase  III  protein,  which  affect  to  
RNA  silencing  efficiency.  I  measured  steady  level  of  Ago2  and  Dicer  protein  by  western  
blot.  The  amount  of  protein  was  not  changed  at  the  time  point  shown  in  the  inhibition  of  
RNAi  activity  (data  not  shown).  Even  though  I  cannot  exclude  the  possibility  the  change  
of  other  protein  of  RISC  complex  having  a  short  half-­  life,  I  concluded  that  major  RNAi  
proteins,   consistent   with   previous   miRNA   biogenesis   data,   are   not   changed   by  
nonspecific  translational  inhibition.  The  alteration  of  RNAi  activity  likely  occurs  in  RISC  
or  RISC  loading,  as  the  steady  state  level  of  miRNA  does  not  change  after  triggering  the  
antiviral  response.  Therefore,  I  investigated  what  molecular  event  of  RISC  occurs  in  cells  
undergoing  the  antiviral  response.    
transfection  of  poly   IC.  Leung  et  al.,  demonstrated   that   the  cytosolic  PARP13   is  a  key  
components   of   stress   mediated   relief   of   RISC   activity.   Using   siRNA   knockdown   of  
PARP13,  I  observed  decreased  poly  IC-­triggered  repression  of  RNAi.  In  summary,  these  
results  argue  that  triggering  the  mammalian  antiviral  response  results  in  the  inhibition  of  
RISC  activity  that  is  partially  dependents  on  PARP13  activity  and  poly  ADP-­ribosylation  
of  Ago2.  
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4.2.5  Viral  infection  inhibits  RNA  interference  
To  test  if  triggering  of  antiviral  responses  with  actual  virus  infection  changes  the  RNAi  
activity,   I   infected   reporter   cell   lines  with   three   different  viruses,  Herpes  Simplex  1   (a  
DNA  virus),  Sendai  virus,  and  Flu  wild  type  and  NS  mt  S42D  (both  negative  strand  RNA  
viruses  known  to  elicit  a  strong  antiviral  response)  (Figure  4.3A).  Infection  with  HSV-­1  
and   Sendai   virus   results   in   relief   of   RISC   activity.   Infection  with   Flu  A   induces   only  
minimal   relief   of   RISC.   However,   infection   with   Flu   mt   relieves   RISC   repression,  
demonstrating   that   this   effect   is   due   to   the   virus   activating   the   host   antiviral   signaling  
response  as  opposed   to   the  virus  directly  blocking  RISC.   In  vitro  RISC  assays  confirm  
that  infection  with  HSV-­1  inhibits  Ago2-­mediated  cleavage  (Figure  4.3B).  Furthermore,  
Ago2  displays  increased  ADP-­R  in  response  to  infection  with  HSV-­1,  Sendai  virus  or  Flu  
mt.   Immunoprecipitation   of   PARP13   studies   show   that   PARP13   is   itself   ADP-­
ribosylated   in   response   to   infection  with   Flu  mt   or  HSV-­1(Figure   4.3C).   Furthermore,  
PARP  13  is  shown  in  greater  association  with  Ago2  upon  infection  (Figure  4.3D).  These  
findings   connect  PARP13  activity   and  association  with  Ago2   to   viral   infection   (Figure  
4.3E).  To  determine  if  ADP-­R  is  required  for  viral-­mediated  relief  of  RISC  activity,  we  
treated   our   RNAi   reporter   cells   with   3AB   (3-­Aminobenzamide)   during   infection   with  
HSV-­1.  Treatment  with  3AB  suppresses  the  RNAi  relief  observed  with  HSV-­1  infection,  
and  this  relief  correlates  in  degree  with  the  amounts  of  ADP-­R  detected  on  Ago2  (Figure  
4.3F).   Therefore,  mammalian   cells   respond   to   infection  with   diverse   viruses   by  ADP-­
ribosylating  PARP13  and  Ago2,  thereby  inhibiting  RISC  activity.  
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Figure  4.3  Viral  infection  inhibits  RNA  interference.  
(A) JM1  reporter  cell  lines  was  infected  with  HSV-­1,  sendai,  or  Influenza  A.  Cells  
were  assayed  for  RNAi  activity:  HSV-­1  strain  7  (a  DNA  virus)  at  10  hours  post  
infection  (hpi).  Same  cell  line  was  infected  with  negative  strand  RNA  viruses,  
sendai  virus  and  influenza  A  virus.  It  was  infected  with  50  HA/ml  sendai  virus  
(indiana  strain)  at  6  hpi.  It  was  also  infected  with  2  MOI  influenza  A  virus  
Ud72  wild  type,  or  Ud72  mt(S42D)  into  JM1  cell  line  at  12  hpi.    
(B) HSV-­1  infection  inhibits  RISC  mediated  cleavage.  in  vitro  RISC  mediated  
cleavage  assay  was  performed  as  shown  in  Fig.2B.  293  cell  extracts  infected  
with  HSV-­1  were  incubated  with  the  P32  radiolabed  pre  miR-­451  to  observe  in  
vitro  RISC  mediated  cleavage  activity.  The  cytosolic  protein  amount  used  was  
????????????????? ??????????? ??????-­Actin.  
(C) Viral  infection  results  in  the  poly  ADP-­ribosylation  of  Ago2.  For  the  detection  
of  poly  ADP-­ribosylatin  of  Ago2,  the  experiments  were  conducted  as  shown  by  
Fig.2C.  293  cells  were  infected  with  HSV-­1,  Sendai  virus,  Flu  A  wild  type  or  
Flu  A  mt.  Immunoprecipitated  Ago2  from  whole  cell  lysates  was  analyzed  by  
western  blot  with  poly(ADP)-­ribose  antibody.    Immunoprecipiated  Ago2  was  
measured  with  Ago2  antibody.  
(D) Viral  infection  induces  the  poly  ADP-­ribosylation  of  endogenous  PARP13.  
PARP13,    a  member  of  the  PARP  family,  is  localized  in  cytoplasm  and  plays  a  
crucial  role  in  the  inhibition  of  RNAi  during  antiviral  response.  
Immunoprecipitated  PARP13  from  whole  cell  lysates  was  probed  with  pADPr  
antibody.    The  amount  of  immunoprecipitated  PARP13  was  measured  with  a  
PARP13  antibody.  
(E) Viral  infection  increases  the  interaction  between  PARP13  and  Ago2  in  the  
cytoplasm.  293  cells  were  infected  with  HSV-­1,  Flu  wild  type  and  Flu  mt,  
respectively.  Whole-­cell  extracts  were  subjected  to  Ago2  immunoprecipitation  
followed  by  immunoblotting  for  the  indicated  protein.  
(F) The  inhibition  of  PARP  activity  blocks  the  depression  of  RNAi  after  infection  
with  HSV-­1.  HSV-­1  triggered  RNAi  inhibition  was  measured  after  treatment  
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4.2.6  The   components   of   the   innate   response   are   responsible   for   the   inhibition   of  
RNAi.    
To  investigate  what  components  of  the  antiviral  response  are  important  for  relief  
of  RISC-­mediated  repression,  I  assayed  a  possible  role  for  interferon.  This  assay  shows  
that   treatment  with   interferon   is  not   sufficient   to   relieve   repression  of  RISC,  but   rather  
augments   the   relief   of   RNAi   activity   that   is   observed   with   pI:C   treatment.   Therefore,  
detection  of  virus  infection  via  an  intracellular  PRR  is  required  to  alleviate  RISC  activity.  
The  previous  evidence  shows  that  an  intracellular  innate  immunity  pathway  triggered  by  
dsRNA  is  responsible  for  the  inhibition  of  RISC.  The  following  two  points  support  this  
assumption.   1)   Viruses   produce   double-­stranded   RNAs   during   virus   replication.   2)  
Transfection  with  a  mimic  of  double  stranded  RNAs  are  sufficient  to  trigger  the  antiviral  
response  and  inhibit  RNAi.  There  are  three  well-­defined  intracellular  dsRNA  pathways,  
1)  MAVS  2)  RNase  L,  3)  PKR.   I  performed   the  poly  ADP-­ribosylation  of  Ago2  assay  
using  mouse  embryonic  fibroblast  cells  (MEFs),  which  are  null  for  either  MAVS,  RNase  
L,  or  PKR  .  MEFs  are  null  of  MAVS  or  RNase  L  both  show  reduced  ADP-­R  of  Ago2  
after   infection  with  HSV-­1,  whereas   PKR  knockout  MEFs   shows   no   difference   in   the  
poly  ADP-­ribosylation  of  Ago2   (Figure  4.4A).  Next,   I   focused  on  MAVS  protein   as   a  
likely   PRR   required   for   the   inhibition   of   RISC   activity.   Indeed,   siRNA-­mediated  
knockdown  of  MAVS  leads  to  decreased  poly  IC-­induced  inhibition  of  RISC  activity.   I  
confirmed  with  Western   blotting   to   assess   siRNA  mediated   knock   down   of   the   target  
protein  (Figure  4.4B).    These  data  show  that  MSVS  contributes  to  the  repression  of  RISC  
that  is  triggered  by  viral  infection  or  chemical  triggers  of  the  antiviral  response.  
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4.2.7  miR-­17  regulates  interferon  stimulated  genes  
The   question   arises   as   to  what   benefit  mammalian   cells   receive   from   inhibiting  RISC  
during   viral   infection.   ADP-­R   of   Ago   leads   to   depression   of   both   siRNA-­mediated  
cleavage  and  miRNA-­mediated  repression  (Leung  et  al.,  2011  and  data  not  shown).  We  
hypothesized   that   relief   of   miRNA-­mediated   regulation   could   allow   for   enhanced  
expression   of   ISGs,  many   of  which   are   toxic   to   cells   and   therefore   likely   to   be   under  
multiple  layers  of  regulation.  We  first  utilized  two  different  bioinformatic  approaches  on  
literature-­??????????????????????????????????????????????also  predicted  to  have  a  higher  
density   of   evolutionarily-­conserved   miRNA   binding   sites   (Figure.   4.5A).   Combined,  
these   analyses   support   that   ISGs,   especially   those   associated   with   cell   death,   are  
particularly   susceptible   to   miRNA-­mediated   regulation.   We   also   undertook   an  
independent   line   of   experimentation   utilizing   DLDExp5-­/-­,   a   human   cell   line  
hypomorphic   for   miRNA   expression   due   to   an   engineered   mutant   Dicer.   We   treated  
miRNA  hypomorphic  cells  or  cells  derived  from  the  isogenic  parental  line  that  expresses  
readily-­detectable   miRNAs      with   IFN   and   performed   microarray   analysis   to   look   for  
differences   in   induction   of   ISGs   .   Indeed,   the   hypomorphs   express   numerous   IFN-­
induced   transcripts   at   higher   levels   than   the   parental   cells   (Figure   4.5B).   Using   the  
Sylamer  algorithm,  we  analyzed   the  differentially   expressed   transcripts   for  evidence  of  
miRNA   regulation.   one   miRNA   family,   miR-­17/93   dominates   (Figure   4.5B).  
Interestingly,   this   family   of   miRNAs   also   was   amongst   our   top-­ranked   miRNAs  
bioinformatically-­predicted  to  regulate  ISGs  and  has  been  previously  shown  to  have  a  
  




Figure  4.  4  The  antiviral  response  pathway  is  involved  in  the  inhibition  of  RNAi.  
(A) MAVS  and  RNase  L  are  involved  in  the  virus  induced  poly  ADP-­ribosylation  
of  Ago2.    The  detection  of  poly  ADP-­ribosylated  Ago2  in  MEFs  was  
performed.  Immunoprecipitated  Ago2  from  whole  cell  lysates  was  analyzed  by  
western  blot  with  poly(ADP)-­ribose  antibody.  Immunoprecipitated  Ago2  
amount  was  measured  with  an  Ago2  antibody.  
(B) MAVS is required for maximal depression of RNAi by treatment with pI:C.  
JM1 reporter cells were transfected with siRNA against GAPDH or siRNA 
against PARP13. Relative fold repression was measured as the activity of 
luciferase (RL/FL) in the pI:C treated cells normalized to untreated cells. The 
relative fold repression by JCV Anti-miR was shown as maximized fold 
repression and a positive control in this assay. Knockdown of MAVS was 
detected with western blot in siMAVS treated cells. The experiment 
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proviral   effect  via   an  unknown  mechanism   (Santhakumar et al.,  2010).  To   test   if  miR-­
17/93  conveys  a  proviral  effect  due  to  it  suppressive  effects  on  ISGs,  we  transfected  cells  
with   a   miR-­93   or   miR-­17   mimic   and   infected   them   with   HSV-­1   in   the   presence   or  
absence  of  IFN  treatment  for  3  hours.  Pre-­expression  of  exogenous  miR17/93  results  in  a  
>3-­fold   increase   in  HSV  virus   yield   in   the   presence   of   IFN  but   only   a   2-­fold   increase  
without   IFN.   This   extends   our   understanding   of   how   miR-­17/93   is   pro-­viral   by  
implicating  a  role   for   these  miRNAs  in  limiting  the  effects  of   IFN  (Figure  4.5C).  Next,  
we  directly  examined  whether  triggering  of  antiviral  response  relieves  ISG  repression.  To  
confirm  that  a  predicted  ISG  is  regulated  by  mir17/93.   I   transfected  whole  cloned  IRF9  
UTR  reporter.  It  was  repressed  with  1.8  fold.  Repression  by  mi17/93  is  decreased  into  1.2  
fold   indicating   depression   under   antiviral   response   triggered   conditions   (Figure   4.5D).    
Thus,   these   data   show   that   relief   of  miRNA   repression  mediated   by   antiviral   response  
results  in  release  of  ISG  transcripts  from  RISC  repression.  As  miRNAs  are  endogenous    
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Figure  4.5  miR-­17  family  regulates  interferon  stimulated  genes  and  promotes  HSV-­1  
infectivity.  
(A) Bioinformatics  strongly  predict  interferon  responsive  genes  are  under  miRNA-­  
mediated  Regulation.  (Data  from  Rodney  Kincaid)  
(B) Mir17  regulates  interferon  stimulated  genes.  (Data  from  Rodney  Kincaid)  
(C) Addition  of  mir17  promotes  HSV-­1  infectivity.  DLD1  Dicer  hypomorph  cells  were    
      transfected with the respective miRNA mimic. After 24 hrs, cells were treated with     
1000 U/ml interferon for 3 hours and then infected with 1 MOI HSV1. Virus was  
     collected after 24 hours and quantified by a plaque assay to observe the infectivity of 
        HSV-1. (Data from Phanaksri  Teva)  
(D)   An   interferon   stimulated   gene,   IRF9,   are   repressed   by  miR-­17/miR-­93   and   after  
treatment  with  pI:C   is  derepresssed.  miRNA-­directed   repression  was   tested  with  a  
renilla  luciferase  reporter  with  a  whole  IRF9  UTR  predicted  to  be  targeted  by  miR-­
17   family.   Renilla   luciferase   and   Firefly   luciferase   reporters   were   co-­transfected  
into  293T  cells  with  5  nM  control  miRNA,  miR-­17  or  miR-­93  mimics  for  24hrs.    To  
observe  the  de-­repression  of  miRNA  directed  repression,  0.5ug  pI:C  was  transfected  
24  hours  after  transfection  with  reporter  plasmids.  To  obtain  the  repression  fold,  the  
luciferase  activity  (RL/FL)  in  miR-­17  or  miR-­93  was  normalized  by  the   luciferase  
acitivity   (RL/FL)   of   control  miRNA   treated   cells   in   the   pI:C   treated   or   untreated  
cells.    
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products  of   the  RNAi  machinery,   these  results  also  show  that  some  RNAi  products  can  
be  considered  proviral  under  IFN-­rich  conditions.  
  
4.3  Discussion    
  
  RNAi  serves   to   actively  defend  against  viral   infection   in   invertebrate  organisms   (Ding  
and  Voinnet.,  2007).  However,  it  has  been  debated  whether  RNAi  plays  an  antiviral  role  
in  mammalian  cells.  It  has  been  unclear  how  RNAi  activity  is  modulated  in  response  to  
viral   infection   in  mammalian   cells.   One   possible   reason   is   that   no   one   assayed   RNAi  
activity   under   cellular   conditions   where   an   antiviral   response   was   engaged.   To   test   if  
RNAi  serves  as  an  antiviral   response   in  mammalian  cells,   I  have  developed  a   sensitive  
method  to  assay  the  alteration  of  RNAi  activity.  However,  the  result  unexpectedly  leads  
to   the   inhibition   of   RNAi.   As   a   mechanism,   RNAi   is   inhibited   by   the   poly   ADP  
riboylation  of  Ago2  after  viral   infection  and  antiviral   response   through  double  stranded  
RNAs  pathway  are  eventually   linked   to   inactivation  of  RNAi.   It   has  been  reported   that  
RNAi   activity   can   be   changed   under   cellular   stress.   It   has   relieved  miR-­122  mediated  
translational   repression  under   cellular   stress   (Bhattacharyya   et   al.,   2006).  Vasudevan  et  
al.,   (2007)   shows   that   serum   starvation   stress   upregulates   miRNA   mediated   gene  
expression.   It   has   been   shown   that   the   cellular   stress   inhibit   miRNA   activity   through  
Ago2    relocalization  or  polyADPribosylation  of  Ago2  (Detzer et al., 2010;;  Leung  et  al.,  
2011).   My   study   shows   that   cellular   response   in   respond   to   viral   infection   modulates  
RNAi   activity   through   a   molecular   pathway.   Completion   of   this   study   detailed   a  
??????????????????????????????????????????????????????????????????mmune  response  in  
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mammalian   cells   (Figure   4.6).   It   is   an   unresolved   question   how   interferon   stimulated  
genes  are  promoted  under  condition  of   translationally  global  downregulation  after  viral  
infection.  As  one  of  possible  explanation,  miRNAs  can  be  possible  key.  miRNAs  mute  
the   target   gene   under   normal   status   without   triggering   of   antiviral   response,   but   once  
virus   triggers   antiviral   response,  miRNA   targets   are   relieved.   I   showed  miR-­17   family  
represses  interferon  stimulated  genes.  However,  it  is  required  to  clarify  the  identification  
of   ISGs  by  other  miRNAs.  mir  142  and  miR-­548  are  also  highly  scored   to   regulate   the  
ISGs   in   bioinformatics   analysis.   The   experimental   demonstration   will   be   a   better  
understanding  the  regulation  of  ISG  by  miRNAs.    
Signal   transduction   for   RNAi   depression   is   mediated   by   MAVS   protein.  
However,  the  downstream  area  is  open  to  question.  Interestingly,  According  to  proteomic  
analysis   in   Li   et   al.,(2011),   the   Ago2   is   bound   to   TBK1   and   TBK1   binding   protein.  
Combined   with   my   previous   data,   Ago2   can   be   regulated   by   MAVS   downstream  
pathway.   Also,   as   a  my   preliminary   data,   p38   inhibitor   blocked   RNAi   inactivation   by  
pI:C.      According   to   paper,   p38   pathways   phosphorylate   Ago2   protein   and   affect   the  
localization   to  P-­body  or   stress  granule   under   the   stress.  P38  MAPK,  a  downstream  of  
MAVS  signaling,  may  regulate  RNA  interference  after  viral  infection.    
Accumulating   data   show   miRNAs   regulate   immune   response   gene   including  
interferon  stimulated  genes  and  RNAi  is  globally  downregulated  in  cancer.  Therefore,  the  
small  molecule  discovery  modulating  microRNA  activity  eventually  might  play  a  major  
role  to  have  a  potential  an  intervention  of  viral  infection.    







                                         
Figure  4.6  Model  for  Role  of  RNAi  During  Viral  Infection  
While RNAi directly blocks viral replication in plants and invertebrates, RNAi in some 
mammalian cells normally represses ISG/antiviral effectors via miRNAs, and therefore is 
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4.4  Materials  and  Methods  
4.4.1  Plasmid  Constructs    
To  perform  the  luciferase  reporter  assay  for  IRF9,  the  full  length  ??????of  IRF9  
including   the  potential  miR-­17   target   site  was  made  by  PCR  using  human  cDNAs  as  a  
template.    Forward  and  reverse  primers  include  XhoI,  XbaI  sites,  respectively.  Amplified  
PCR   product   was   subcloned   into   pcDNA3.1   puroRenLuc   expression   vector.    
pcDNA3.1puroRen   Luc   MCV   miRNA   binding   site   and   pcDNA3.1puroFirefly   Luc  
plasmids   (Seo  et   al.,  2009)  were  used   to  establish  MM35  cell   lines.     MCV  pri-­miRNA  
including   flanking   region  was   subcloned   from   pcDNA3.1puroMCVmiRNA   expression  
vector  into  pcDNA3.1hygro  vectors  using  restriction  enzymes,  HindIII/XbaI.  To  explore  
miRNA-­mediated   derepression,   perfectly   matched   JCV   miRNA   binding   site   were  
replaced   with   bulged   JCV   miRNA   binding   sites   by   PCR   mutagenesis   and   cloning   as  
shown  by  John  et  al.,(2003).  The  sequences  are  same  with  original  vector  except  bulged  
region.    
  
4.4.2  Stable  cell  line  derivation  
Stable  Mo,   JM1  cell   lines  have  been  described   in  McClure   et   al.(2011).  MM35  
cell  lines  were  made  by  two  antibiotic  selections  as  shown  in  the  derivation  of  JM1  cell  
lines.      To   make   parental   cell   lines   stably   express   both   Rennila   Luc   and   Firefly   Luc  
reporter   genes,   293   cell   lines   were   puromycin   selected   co-­transfection   with  
pcDNA3.1puroRen   Luc   MCV   miRNA   binding   site   and   pcDNA3.1puroFireflyLuc  
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plasmids.      Stable   clone   were   confirmed   by   Luciferase   assay.   Next,  
pcDNA3.1puroMCVmiRNA   expression   vector   was   transfected   into   parental   cells   and  
selected  by  hygromycin  B.  Stably  cloned  MM35  cell  lines  was  used  during  experiments.    
  
4.4.3  Cell  culture  and  Reagents  
HEK  (Human  embryonic  kidney)  293  derived  Mo,  JM1,  JM19,  MM35  cells,  wild  
type   MEFs   (Mouse   embryonic   fibroblasts)   and   MAVS   knockout   MEFs   (gifted   from  
Chen   lab,  UT   southwestern  medical   school)   were   cultured  with  DMEM   supplemented  
with   10%   fetal   bovine   serum   and   antibiotics.   Wild   type   MEFs,   RNase   L   knock   out  
MEFs,  and  PKR  knockout  MEFs  were  maintained  with  RPMI  1640  supplemented  with  
10%  fetal  bovine  serum  and  antibiotics.  DLD1  Dicer  hypomorph  cells  were  cultured  with  
M??????? ??????? ????????????? ????? ???? ?????? ??????? ?????? ???? ????????????? ????
following   reagents  were   commercially  obtained;;  pI:C   (in  vivogen),   3-­Aminobenzamide  
and  Arsenite  (Sigma),  PARP13  antibody  (Abcam),  Monoclonal  Ago2  antibody  (sigma),  
Monoclonal  mouse  Ago2   antibody   (Wako),  Actin   antibody   (santa   cruz   biotechnology),  
pADPr  antibody   (Amersham),  MAVS  (Bethyl   laboratories).  Ago2  7C3  antibodies  were  
kindly  gifted  from  Hobman  lab  (University  of  Alberta,  Canada).  
  
4.4.4  Dual  luciferase  reporter  assay     
                        Mo,  JM1  cells  were  first  seeded  in  a  T75  flask  at  80%  confluency.  The  medium  
was  removed  and  the  cells  were  gently  rinsed  with  5  mL  of  D-­PBS.  One  mL  of  trypsin-­
EDTA  was  added  and  the  flask  was  tapped  vigorously  for  approximately  30  seconds  to  
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detach  and  resuspend  cells.  The  trypsin  reaction  was  quenched  by  resuspending  cells  in  9  
mL  of  growth  medium  using  a  serological  pipette.  Cells  were  centrifuged  at  3300  x  g  for  
3  minutes   and   the   supernatant  was  discarded.  The  pellet  was   resuspended   in  10  mL  of  
growth  medium   by   gently   pipetting.  A   single   T75   flask   contains   enough   cells   to   seed  
approximately   three   or   four   12-­well   plates.   For   one   12-­well   plate,   3.3   ml   of   cell  
resuspension  was  added  to  10  ml  of  growth  medium  and  1000  µl  was  added  to  each  well.    
Treatment  with  poly  IC  
One  day  after  seeding  cells,  each  well  of  12-­well  culture  plate  was  transfected  with  2  µl  
of  Lipofectamine  2000  and  0.5  µg  pI:C  in  200  µl  of  DMEM.  After  mixing  with  reagents,  
The  mixture  was  incubated  for  15  min  at  room  temperature.  Standard  poly  I:C  treatment  
lasted  8hrs  before  assaying  RNAi  activity  except  for  the  time  course  assay  in  which  poly  
I:C  treatment  lasted  0-­24hrs.  
Viruses  infection  
HSV-­1   strain   17  was   obtained   from  Craig  McCormick   (Dalhousie  University).   Sendai  
virus  was  purchased  from  Charles  River.   Influenza  virus  A  wild  type  and  Flu  mt  S42D  
was  gifted  from  Robert  Krug  (University  of  Texas  Austin).  JM1  cell  lines  or  MEFs  were  
infected  with  10  MOI  HSV-­1,  50  HA/ml  sendai  virus  or  2  MOI  Flu  A  WT  or  Flu  A  S42D  
viruses  at  37  °C.  For  luciferase  assays,  cells  infected  with  Sendai,  HSV-­1  and  Flu  viruses  
were   lysed   at   6,   10,   12   hpi,   respectively.   The   growth  medium  was   removed   using   an  
aspirator  and  250  µL  per  well  of  room  temperature  passive  lysis  buffer  was  added  to  each  
well.  Cells  were  incubated  for  15  minutes  at  room  temperature  to  ensure  lysis.  The  dual  
luciferase   assay   was   performed   using   a   Luminoskan   Ascent   Luminometer   (Thermo  
   84  
Electronic   Corporation,   Milford,   MA).      50   µL   of   LAR   II   was   added   to   read   firefly  
luciferase  enzyme  activity  and  recorded   the  results.  50  µL  of  Stop  &  Glo  was  added  to  
read   renilla   luciferase   enzyme   activity.   Normalization   compared   treated   cells   to   an  
untreated  control.  The  replicates  were  averaged.    
  
4.4.5  Transient  assay  to  detect  miRNA-­mediated  depression  
2x105  293T  cells  were  seeded  in  a  12  well  culture  plate.  A  plasmid  mix  containing  100  
ng   Firefly   luciferase   expression   vector,   100ng   renilla   luciferase   expression   vector   and    
1.6  µg  empty  vector  or  5  nM  miRNA  mimics  (control  miR,  MCV  miR,  JCV  miR,  miR-­
17,  and  miR-­93)  was  transfected  into  cells  for  18  hrs.  The  5nM  concentration  of  miRNA  
mimics   showed   a   maximum   derepression.      Cells   were   treated   with   250   µM   Sodium  
Arsenite  for  90  min  or  pI:C  was  transfected  for  8  hrs.  Cell  were  carefully  washed  with  D-­
PBS   and   lysed   with   1   X   Passive   Lysis   Buffer   (Promega).   Luciferase   activity   was  
measured  on  all  the  above  conditions.  
  
4.4.6  Northern  blot  and  miRNA  northern  blot  analysis  
Northern   blot   for  miRNA   detection  was   done   as   described   in   Seo   et   al.,   (2008).   Total  
RNA  for  northern  blot  analysis  was  isolated  from  cells  by  Trizol  (GIBCO  BRL)  reagent.  
RNA  was  run  in  a  0.8%  agarose  gel  containing  0.22  M  formaldehyde  at  90V  for  2  hrs.  
The  RNA  was  transferred  to  a  nylon  membrane  and  fixed  by  UV  cross-­linking.  The  filter  
was   hybridized   at   55   °C   overnight   with   a   radioactively   labeled   probe   in   ExpressHyb  
solution   (Clontech),   then   rinsed   twice  with  2  ×  SSC,  0.05%  SDS     at   room   temperature  
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and  finally  with  0.1  ×  SSC,  0.1%  SDS  for  60  min  at  50°C.  The  probe  was  stripped  from  
the   blot  with   0.5%  SDS   at   90°C   for   10  min.  The   filter  was   then   re-­equilibrated   in   the  
ExpressHyb  solution  and  reprobed  with  a  new  sequence.  The  hybridization  signals  were  
quantitated  by  scanning   the  membrane  with  a  PhosphoImager  (Molecular  Dynamics)  or  
film  was  added  to  the  blot.  
  
4.4.7  RNA  interference  
Chemically  synthesized  21-­nucleotide  siRNAs  was  purchased  from  Dharmacon,  and  IDT  
DNA.  Cells  were      twice  transfected  with  20nM  siRNAs  within  96  hrs.  First,  cells  were  
transfected  with  20  nM  siRNAs  collected  after  48  hrs.  The  collected  cells   split   into  12  
well  culture  plates  for  the  second  siRNA  treatment.  
  
4.4.8  Western  blot  
Cytoplasmic   lysis   buffer   was   used   to   extract   proteins.   Buffer   consisted   of;;   50Mm  
HEPES,   pH   7.4,   150  mM  NaCl,   1mM  MgCl2,   1  mM  EGTA,   1%  Triton  X-­100,   1mM  
DTT,   1   mM   ADP-­HPD   (EMD)   and   Complete   EDTA   free   protease   inhibitor   cocktail  
(Roche).   Cell   extracts   were   subjected   to   10%   SDS-­polyacrylamide   gel   electrophoresis  
and  immunbloted  antibodies  specific  to  each  experiment:  (?-­Actin,  PARP13,  MAVS).    
  
  
4.4.9  In  vitro  Ago2  cleavage  assay  
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We   adapted   a   Zebrafish   in   vitro   Ago2   cleavage   assay   into   mammalian   cell   culture  
(Cifuentes  et  al.,  2010).  
Treatment  with  pI:C  and  virus  infection  
HEK   293   cells  were   used   for   the   assay.     Mock   or   pI:C     was   transfected   into   12  well  
plates.   One   day   after   seeding   cells,   each   well   was   transfected   with   a   mixture   of  
Lipofectamine  2000  and  pI:C.  Each  well  contained  2  µl  of  Lipofectamine  2000  and  0.5  
µg     pI:C   in  200  µl  of  DMEM.     poly   I:C   treatment  proceeded   for  8hrs.   Infections  were  
carried   out   under   the   same   cell   culture   conditions.   10   MOI   HSV-­1   infections   were  
harvested  after  0,  3,  6  hpi.    
Preparation  of  cell  extracts    
  Cell   extracts  were  prepared   as  described   (Gunter   et   al.,2004).  5  x  109     HEK  293   cells  
were   collected   by   centrifugation   and   washed   with   D-­PBS.   The   cell   pellet   was  
resuspended   in   five   pellet   volumes   of   cell   lysis   buffer   including   protease   inhibitor  
(Roche)  and  incubated  for  10  min  on  ice  and  collected  again  by  centrifugation.  The  cell  
pellet  was  resuspended  in  2  pellet  volumes  and  sonicated  for  3  miniute.  The  cell  debris  
was   removed   from   the   cell   lysate   by   centrifugation   at   1000   g   for   2   min   and   the  
supernatant   was   further   centrifuged   at   15000g   to   obtain   the   cytoplasmic   extract.   The  
concentration   of  KCl   of   the   extract  was   raised   to   100mM  by   addition   of   concentrated  
KCl.  The  extract  was  then  adjusted  to  a  glycerol  content  of  10%  and  immediately  frozen  
in  liquid  nitrogen.  
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Immunodepletion  assay  
  25  µl  of  bead  slurry  was  put  into  0.5ml  tubes.  It  was  washed  with  buffer  three  times  and  
then  4µg  of   rabbit   Ig  G  or  4µg  of  polyclonal   anti-­Ago2   (7C3)  was   added  bringing   the  
volume  to  400  µl.  Beads  were  incubated  with  each  antibody  at  4  °C  for  1  hr  on  a  rotator  
to   allow   the   antibody   to   bind   to   the   beads.   The   sample   was   centrifuged   at   4   °C   and  
washed  with  buffer.  150-­200  µl  of  cell  extracts  was  transferred  to  the  precipitated  beads  
and  incubated  at  4  °C  for  1  hr  on  a  rotator.    Supernatants  were  followed  by  in  vitro  RISC  
mediated  cleavage  assay  and  western  blot.      
  in  vitro  RISC  mediated  cleavage  assay  
Gel  purified  pre-­miR451  was  purchased  from  Dharmacon.  The  sequence  is    
The  pre-­miR451  was   freshly  phosphorylated  prior   to  use  by   incubating   in  a  1µM  PNK  
buffer  containing  10  units  T4  PNK(NEB)  for  30min  at  37  °C  ,  followed  by  purification  
with      illustra  microspan  G-­25  columns   (GE  healthcare).  1  ????????? ???? ???????????????
was  incubated  in  10  µl  volume  containing  20  Mm  HEPES-­HCL,  pH  7.0.  100  mM  KCL.  
The  cleavage  reaction  was  performed  for  15  min  at  37  °C.  The  final  reaction  volume  was  
30  µl.  The  reaction  was  stopped  by  the  addition  of  5  x  gel  loading  buffer  (25%  glycerol,  
0.5%   SDS,   50mM   EDTA,   0.25%   bromophenol   blue,   0.25%   xylene   cyanol)   and  
proteinase   K,   incubated   for   30   min   at   room   temperature,   and   then   heat   denaturated   (  
95  °C,  1  min).The  samples  were  loaded  directly  onto  a  15%  denaturing  polyacrylamide  
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gel.   Radioactive   Gels   were   exposed   to   Phosphor   imager   (Molecular   Dynamics),   or  
exposed  to  film.  
Immunoblot  
Cell   extracts   were   subjected   to   10%   SDS-­polyacrylamide   gel   electrophoresis   and  
????????????????????????????????????????-­Actin.    
4.4.10  Detection  of  the  poly  ADP?ribosylation  Ago2  
293  cells  were   transfected  with  pI:C   into  12  well  culture  plates  or   infected  with  
HSV-­1,   sendai   virus,   and   influenza   virus   A.     MEFs   in   a   150   cm2   cultured   plate   were  
infected   with   HSV-­1.   Cells   were   collected   by   scraping   the   culture   flasks   and   washed  
twice  with  D-­PBS.     Buffer  C  was  applied  to   the  cell  pellet  as  previously  described.     40  
min   before   harvesting   cells,   0.5   mg/ml   latrunculin   B   was   added.   Cell   lysate   was  
centrifugated  at  maximum  speed  for  10  min,  transferred  into  new  tubes  and  treated  with  a  
final   concentration   of   10mg/ml   cytochalasin   B   and   25  mM   nocodazole.   To   detect   the  
poly  ADP-­ribosylation  of  Ago2,  2ug  of  Ago2  monoclonal  antibody  (Sigma)  or  a  mixture  
with  mouse  Ago2  and  Ago2  monoclonal  antibody  (in  MEFs,  WAKO)  was  preincubated  
with  protein-­G  beads.  The  beads  were  washed   three   times  with  buffer  C   for  15  min  at  
4   °C   before   applying   sample   buffer   and   heating   for   10   min   at   70   °C.   Half   of  
immunoprecipitated   samples   were   used   for   the   western   blot.   Immunoprecipitates   were  
subjected  to  10%  SDS-­polyacrylamide  gel  electrophoresis  and  immunobloted  with  each  
antibody:  Ago2,  PARP13,  or  pADPr.    
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4.4.11  Plaque-­forming  assay  
 miRNAs   
Mission® miRNA mimics and negative control were purchased from sigma.  
Cells and culture condition  
DLD1 cells were ???????????? ?????????? ????????????????????????????????????????
???????????? ????????? ?????????????? ?????-glutamine, and 10% bovine serum albumin 
(BSA). Vero cells were cultured in DMEM (CellGlo) supplemented with antibiotics, L-
glutamine and BSA. For miRNA transfection, cells were cultured complete medium 
without antibiotics. Cell culture was done at 37 °C with 5% CO2 in humidity condition. 
?????????????????????????????????????? 
        DLD1 dicer hypermorp cells were plated in 6-well plate for 24 h before transfection. 
Each miRNA was transfected into the cells at 10nM using TranIT-siQuest® transfection 
???????? ???????? ?????????? ??? ???? ?????????????? ?????????? ??????-four hour 
posttransfection, Cells were treated with 1,000U/ml Universal Type I Interferon (PBL 
InterferonSource) for 3 hours. After interferon treatment, cell was infected with HSV-1 at 
1 M.O.I for an hour. Cell was washed once with PBS to remove unbound virus and then 
?????????????? ??????????????????? medium. Cell culture medium was collected and 
stored at -80 until plaque assay at two days post HSV-1 infection. 
HSV-1 plaque assay 
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        Vero cells were seeded into 6-well plate to obtain 100% confluent before HSV-1 
infection. The medium containing virus was diluted to several dilutions (10-3-10-5). Cells 
were incubated with HSV-1 solution for an hour (duplicate for each dilution). After 
infection, medium was removed and replaced with overlay medium containing 2% 
methylcellulose. When plaque formation (2-3 days), cell was fixed with 4% 
paraformaldehyde for 10 min and washed several times with PBS to remove trace 
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Chapter  5:  Thesis  Significance  and  Future  Work  
  
DNA   viruses,   including   polyomaviruses   and   herpesviruses,   encode   miRNAs,  
though   their   functions   are   not  well   defined.  The   primate   polyomavirus   SV40,   a  model  
system,  encodes  miRNAs.  Human  polyomaviruses  (JCV,  BKV,  and  MCV)  are  known  to  
exist,   but   when   I   began   my   thesis   work,   it   was   unknown   whether   they   also   encoded  
miRNAs.  Identifying  miRNAs  from  additional  polyomaviruses  has  the  great  potential  of  
fostering   a   better   understanding   of   polyomaviridae   biology   as   well   as   viral   miRNA  
function.   Researchers   have   developed   technologies   to   hunt   new   viral   miRNAs.   By  
bioinformatic   prediction   and   confirmation   by   northern   blot   approach,   I   have   identified  
polyomaviral   miRNAs   that   have   a   functional   conservation.   However,   this   does   not  
preclude   the   fact   that   additional   miRNAs   could   be   expressed   from   other   genomic  
locations   of   polyomavirus.   Furthermore,   even   though   the   miRNAs   that   have   been  
identified  from  polyomaviruses  have  been  extensively  studied,  it  is  worth  exploring  what  
miRNAs   are   derived   from   emerging   polyomaviruses.   For   example,   the   WU,   or   KI,  
viruses   that   are   possibly   involved   in   respiratory   tract   disease  may   have   a   small   RNA.  
Different   approaches   to  miRNA  hunting,   such  as  miRNAs  deep   sequencing   from  bona  
fide  polyomavirus-­infected  samples  might  yield   information   to  answer   the  question  and  
lead  to  more  information  for  studying  polyomaviral  biology.    
Another  question  is  the  function  of  viral  miRNAs  in  vivo.  In  2009,  Sullivan  et  al.,  
found   that   murine   polyomaviral   miRNA   is   not   required   for   in   vivo   infection   in   some  
experimental  conditions.  However,   it   remains   to  be  studied  whether   the  viruses   lacking  
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viral   miRNAs   have   a   sustainable   infectivity   under   conditions   that   mimic   natural  
transmission.   In   addition,   it   would   be   interesting   to   test   whether   the   primate  
polyomavirus-­virus  encoded  miRNAs  in  different  genomic  locations  affect  the  viral  life  
cycle   in   the   in   vivo   environment.   Further   study   may   provide   clues   for   the   molecular  
intervention  for  human  polyomavirus-­related  diseases.      
RNAi  serves  to  actively  defend  against  viral  infection  in  invertebrate  organisms.  
However,  researchers  debate  whether  RNAi  plays  an  antiviral  role  in  mammalian  cells.  It  
has  been  unstudied  how/if  RNAi   activity   is  modulated   in   response   to  viral   infection   in  
mammalian  cells.  One  possible  reason  is  that  they  have  not  been  assayed  under  cellular  
conditions  during  an  actual   infection.  To  test   if  RNAi  serves  as  an  antiviral  response  in  
mammalian   cells,   I   have   developed   a   sensitive  method   to   assay  RNAi   activity.   I   have  
demonstrated   that  RNAi   is   inhibited  by   the  poly  ADP  riboylation  of  Argonaute  protein  
after   viral   infection;;   antiviral   response   through   double-­stranded   RNAs   pathway   is  
eventually  linked  to  inactivation  of  RNAi.  Completion  of  this  study  detailed  a  previously  
???????? ??????? ?????? ???????? ????? ???? ???? ??????? ??????? ????????? ??? ??????????
cells.   It  is  an  unresolved  question  how  the  expression  of  interferon-­stimulated  genes  are  
promoted  under  the  condition  of  global  downregulation  of  translation  after  viral  infection.  
One  possible  explanation  suggests  that  miRNAs  could  be  a  possible  key.  miRNAs  mute  
the  target  gene  under  normal  status  without  triggering  an  antiviral  response,  but  once  the  
virus   triggers   an   antiviral   response,   miRNA   targets   are   relieved.   Together   with   my  
Sullivan  lab  collegaue,  I  showed  that  the  miR-­17  family  of  miRNAs  represses  interferon-­
stimulated  genes.  What   is  necessary,  however,   is   to  determine  other   ISGs  and  miRNAs  
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involved  in  reguilation  of  the  antiviral  response.  R.  Kincaid  has  shown  that  miR-­142  and  
miR-­548  are  also  highly  scored  to  regulate  the  ISGs  in  bioinformatics  analysis  (Kincaid  
and   Sullivan,   unpublished).   The   experimental   demonstration   will   provide   a   better  
understanding  of  the  function  in  ISG  by  miRNAs.    
Signal  transduction  for  RNAi  repression  is  mediated  by  MAVS  protein.  However,  
effectors   of   this   process   that   lie   downstream  of  MAVs   remain   unknown.   Interestingly,  
according  to  proteomic  analysis  in  Li  et  al,  2011,  the  Ago2  protein  is  bound  to  TBK1  and  
TBK1-­binding  protein  (SINTBAD).  Since  TBK1  and  TBK2  are  downstream  effectors  of  
MAVS,  it  is  likely  that  they  paly  a  role  in  the  regulation  that  I  have  discovered.  Also,  as  
part  of  my  preliminary  data,  a  p38  MAPK  chemical  inhibitor  blocked  RNAi  inactivation  
by   pI:C.      According   to   Zeng   et   al.,(2008),   p38  MAPK   pathways   phosphorylate   Ago2  
protein  and  affect  the  localization  of  P-­body  or  stress  granule  under  the  stress.  Therefore,  
p38  MAPK,   a   downstream   of  MAVS   signaling,   may   regulate   RNA   interference   after  
viral  infection.    
Another  possible   experiment  would  be   to   test  whether   autophagy   is   involved   in  
the  inhibition  of  RNAi.  Ago2  was  originally  known  as  endoplasmic  or  golgi?membrane-­
bound   protein   and   the   cellular   endoplasmic   membrane   snatching   occurs   during   the  
autophagy  process  after  viral  infection  (Kim  et  al.,  2010).    According  to  my  preliminary  
data,  autophagy-­related  PI3  kinase  inhibitor,  3-­  Methyladenine,   inhibited  RNAi  by  pI:C  
and  sendai  virus  infection.  It  will  be  interesting  to  test  whether  autophagy  is  involved  in  
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the  inhibition  of  RNA  using  the  knock-­down  approach  by  the  autophagy  gene  siRNA  in  
JM1  cells.    
Furthermore,  it  would  be  interesting  to  test  if  RNAi  is  inactivated  in  response  to  
microbial   infection.   Cellular   oxidative   stress   inhibits   miRNA   activity.   According   to  
kuldow   et   al.,(2012)   RNAi   is   globally   repressed   by   microbial   infection   in  C   elegans.  
Some  bacteria,  infectious  to  the  cell,  cause  oxidative  stress.  Therefore,  bacterial  infection  
may  affect  RNA  interference.    It  would  also  be  an  exciting  experiment  to  test  if  Toll-­like  
receptors  are   involved   in   the   inhibition  of  RNAi  using  LPS  or  pI:C.  However,   this   has  
been  a  limitation  in  performing  the  pilot  study  because  JM1  cells  derived  from  293  cell  
lack  TLR  3,  4  receptors  recognizing  experimental  ligands  such  as  extracellular  pI:C,  LPS,  
respectively.   A   possible   experiment   can   be   performed   after   transient   TLR   3   or   4  
expression   in  JM1  cells.  Or  Stably  TLR3  or  4  expressed  293  cell   lines  can  be  used  for  
transient  reporter  assay  to  measure  RNAi  activity.    
Accumulating   data   show   miRNAs   regulate   immune   response   genes,   including  
interferon-­stimulated  genes  and  RNAi  is  globally  downregulated  in  cancer  (O'Connell  et  
al.,  2012;;  Melo  et  al.,  2011)  .  Therefore,  the  discovery  of  the  small  molecule  modulating  
microRNA   activity  might   eventually   play   a  major   role   in   producing   a   potential   cancer  
therapy   or   being   an   intervention   of   viral   infection.   The   JM1   cell   lines,   used   for  
monitoring  RNAi  activity,  could  be  a  useful  platform  for  performing  the  high  throughput  
screening  analysis  to  discover  a  small  molecule  modulating  miRNAs  activity.  As  a  side  
note,   3-­   aminobenzamide,   is   clinically   used   for   cancer   therapy,   in   which   it   shows   the  
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inhibition   of   RNAi   depression   after   triggering   antiviral   response   in   cytoplasm.      In  
summary,  my  study  to  understand  a  viral  miRNA  and  RNA  interference  during  viral  life  
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